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ABSTRACT
Polycyclic aromatic hydrocarbons (PAHs) are some of the most common and toxic
pollutants encountered worldwide. Presently, monitoring is restricted to sixteen PAHs, but it is
well understood that this list omits many toxic PAHs. Among the “forgotten” PAHs, isomers with
molecular weight 302 are of particular concern due to their high toxicological properties. The
chromatographic analysis of PAHs with MW 302 is challenged by similar retention times and
virtually identical mass fragmentation patterns.
The first original component of this dissertation evolves from a high-resolution
spectroscopic approach specifically developed to fulfil this gap. Herein, 4.2 K Laser-Excited TimeResolved Shpol’skii Spectroscopy (4.2K LETRSS) is applied to the analysis of HMW-PAHs in a
complex coal tar standard reference material (SRM 1597a). The spectral and lifetime information
obtained with LETRSS provide the required selectivity for the unambiguous determination of PAH
isomers in the high-performance liquid chromatography (HPLC) fractions. Complete LETRSS
analysis is possible with microliters of HPLC fractions and organic solvent. The excellent
analytical figures of merit associated to its non-destructive nature, which provides ample
opportunity for further analysis with other instrumental methods, makes this approach a unique
alternative for the analysis of isomers of HMW-PAHs in complex environmental samples.
The second original component of this dissertation focuses on the development of
screening methodology for the routine analysis of PAH metabolites in urine samples. It explores
the

room-temperature

fluorescence

benzo[a]pyrene-trans-9,10-dihydrodiol,

(RTF)

properties

of

3-hydroxy-benzo[a]pyrene,

benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol

and

benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol previously extracted with octadecyl-silica
iii

membranes. RTF measurements from extraction membranes are carried out with the aid of fiber
optic probe that eliminates the need for manual optimization of signal intensities. Relative standard
deviations varying from 2.07% (benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol) to 8.55% (3-hydroxybenzo[a]pyrene) were obtained with a straightforward procedure. Analytical recoveries from
human urine samples varied from 87.54 ± 3.11% (3-hydroxy-benzo[a]pyrene) to 99.77 ± 2.48%
(benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol). The excellent analytical figures of merit and
the simplicity of the experimental procedure demonstrate the potential of Solid phase extractionRTF for screening biomarkers of PAH exposure in numerous urine samples.
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CHAPTER 1. INTRODUCTION
1.1. Photoluminescence Phenomena
A partial Jablonski diagram, depicting the various activation and deactivation processes for
an aromatic molecule, is shown in Figure 11. An absorption, or excitation, process (A) can occur
into the first or higher excited singlet state. Excitations into the first and second singlet states (S 1
and S2) are shown. This process is relatively fast and it takes approximately 10-15 s. Following
excitation, the molecule typically undergoes vibrational relaxation (VR) into the ground
vibrational level of the electronic excited state. The excess of vibrational energy is converted to
thermal and/or translational energy. VR occurs on the order of 10-11 to 10-10 s. If the molecule
resides in an upper excited singlet state (S2), internal conversion (IC) into the S1 electronic level
can occur. This process is efficient if the ground vibrational level of the S2 state has the same
energy as an upper vibrational lever of the S1 state. The internal conversion process occurs on
order of 10-12 s. Following IC, VR occurs into the ground vibrational level of the S1 state.
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Figure 1. Jablonski diagram. A is absorption, F is fluorescence, P is phosphorescence, VR is vibrational relaxation,
IC is internal conversion, and ISC is intersystem crossing.

2

From the S1 state, deactivation of the molecule may happen through various processes.
External conversion (EC) is a non-radiative deactivation process in which the excited molecule
transfers its excess electronic energy to surrounding molecules or solvent molecules through
collisions. From the lowest vibrational level of S1, the molecule may also release the excess of
electronic energy in the form of a photon. This process is known as fluorescence (F) and it occurs
on order of 10-10 to 10-6s. Since IC and VR are comparatively rapid process, fluorescence most
often occurs from the ground vibrational lever of the first excited single state and it is of a longer
wavelength than absorption. Fluorescence from the S2 state is rare and will only occur if the energy
gap between the S1 and S2 states is large enough that IC is not favoured.
The S1 state also may be deactivated by a non-radiative process called inter-system crossing
(ISC). This process involves a crossover of electronic states similar to IC but it occurs between
states of different spin multiplicity. Population of the upper vibrational levels of the triplet state
manifold is followed by VR and IC into the ground vibrational level of the first triplet excited state
(T1). Deactivation of T1 via the emission of a photon is called phosphorescence (P) and it occurs
on the order of 10-3 to 103 s. Since phosphorescence occurs on a relatively long time scale, T1 is
particularly susceptible to collisional deactivations2. Non-radiative deactivation of T1, or
quenching, can be significant in the presence of oxygen. Molecular oxygen resides naturally in a
ground triplet configuration possessing two low-lying singlet states with excitation energies of
approximately 23 and 38 kcal/mol. Any species having excitation energy as low as 23 kcal/mol
may be quenched by oxygen via energy transfer. Excited singlet states may also be affected by
oxygen, but since oxygen quenching is diffusion controlled, a high oxygen concentration is
necessary to quench the relatively short-lived excited singlet state.
3

The removal of oxygen is often accomplished through de-oxygenation of sample solution
by purging the sample compartment with inert gasses. Similar to phosphorescence, fluorescence
is always in competition with the various non-radiative deactivation processes of the excited state.
As a result, fluorescence and phosphorescence intensities intrinsically depend on the relative
efficiencies of all competing processes affecting their respective excited states. The efficiencies of
fluorescence and phosphorescence are often expressed in terms of quantum yields (  ).
The quantum yield for fluorescence (  F ) is the ratio between the rate of fluorescence and
the rate of absorption, ΦF/ФA, where ΦF = kFnS1V and ФA = kAnS0V. V is the volume of sample
illuminated; nSx is the number of molecules occupying the given electronic state x; and k F and kA
are the rates of fluorescence and absorption, respectively. Under steady state conditions, we can
assume that nS1 = nS0kA/ (kF + knr), where knr is the sum of rates for the non-radiative processes
(external conversion, kec; internal conversion, kic; and inter-system crossing, kisc). Using these
relationships, the fluorescence quantum yield in terms of the rate constants of the various activation
and deactivation processes is given by equation (1.1):

F 

kF
k F  knr

(1.1)

Which shows that, in order to improve the fluorescence quantum yield, and hence the
fluorescence intensity, one needs to minimize the rate contributions from non-radiative
processes .A similar situation arises for phosphorescence. The phosphorescence quantum yield
(  P ) can expressed as:

P 

kisc
kP

kisc  k F  knr k P  k nr

(1.2)
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Note that the first term in equation (1.2) takes into account the efficiency of inter-system
crossing. Therefore, to maximize the phosphorescence efficiency, hence the phosphorescence
intensity, minimization of both non-radiative processes and fluorescence relative to inter-system
crossing becomes evident.
Because the excited states (S1 and T1) are often deactivated by first-order processes, the
decay of either fluorescence or phosphorescence can described by equation (1.3):

I t  I 0 e t /  L

(1.3)

Where I0 is the luminescence (fluorescence or phosphorescence) intensity at time zero and
τL is the luminescence lifetime. The lifetime decay is defined as the time it takes for the
luminescence signal to decay to 1/e of its initial value. The lifetimes for fluorescence and
phosphorescence are related to the rate constants for deactivation by equations (1.4) and (1.5):

 F  (k F  k nr ) 1

(1.4)

 P  (k P  k nr ) 1

(1.5)

Equations (1.1), (1.2), (1.4) and (1.5) indicate that non-radiative decay processes decrease
the fluorescence and phosphorescence intensities and lifetimes by the same factor. In other words,
the lifetime and the quantum efficiency are proportional to (kL + knr)-1.
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1.2. Shpol’skii Spectroscopy
Apart from possible instrumental contributions, inhomogeneous and homogeneous
broadening effects determine the spectral line-width in condensed phase electronic spectra.
Inhomogeneous broadening is related to the fact that in a sample we are usually studying a large
ensemble of molecules that – although chemically identical – may still show slightly different
spectra. That is mainly the result of differences in the structure of the solvation shell surrounding
the chromophore molecules: each individual molecule will experience a slightly different
interaction with the solvent, resulting in a Gaussian distribution of transition energies (as illustrated
in Figue 2a. In flexible molecules, the occurrence of different conformations may also play a role.
However, when solute molecules adopt the same conformation and experience exactly the same
environment, such as the one in a theoretically perfect crystalline matrix, their transition energies
would coincide exactly, as shown in Figure 2b.

Figure 2. Cartoon of analyte in amorphous and crystalline matrix and resulting spectral bandwidth.
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In practice, the inhomogeneous broadening can strongly be reduced but not completely
removed. Typical bandwidths in Shpol’skii experiments carried out in n-alkane matrices at
temperatures of 20k or lower are 1-3 cm-1. That is sufficient to obtain vibrational resolved spectra,
but in low-temperature single-molecule experiments, thousand-fold narrower transitions have been
observed3. Homogeneous broadening factors affect each individual molecule to the same extent.
In condensed-phase spectroscopy, it originates mostly from electron-phonon interactions. A
phonon is a quantized lattice vibration of the matrix. During an electronic transition, one or several
lattice vibrations can be simultaneously excited.
The homogeneous spectrum will therefore consist of a superposition of a narrow zerophonon line (ZPL) and a broad phonon side band or phonon wing (PW) as shown in Figure 3. In
emission the PW appears as a broad continuum at the low-energy side of the ZPL and in absorption
at the high-energy side. In a low-temperature environment, this phonon sideband is often well
distinguishable from the ZPL, as shown in Figure 3. For most applications one would like to obtain
strong ZPLs, which means that the temperature should be as low as possible, and solute-matrix
interactions should be weak. Both requirements are usually met when working under cryogenic
conditions with non-polar compounds in an n-alkane matrix, but other solute-matrix combinations
have also shown Shpol’skii-type spectral narrowing.4, 5
The intensity (I) may be described in the form:

I ( , T )  I ZPL ( , T )  I PW ( , T )

(1.6)

Where Ƭ is time and v is frequency. The relative intensity of the ZPL can be characterized
by the Debye-Waller factor α (T),
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 (T ) 

I ZPL
 exp[ S (T )]
I ZPL  I PW

(1.7)

Where S, the so-called Huang-Rhys parameter, is a dimensionless quantity that indicates
the strength of the electron-phonon coupling as a function of temperature.4

Figure 3. Electron phonon coupling in emission. On the left side three of the many possible phonons are shown,
present in a number of overtones. The zero phonon transitions for all phonons coincide, resulting in a sharp zerophonon line (ZPL). The phonons and their overtones do not overlap exactly and show up as a broad phonon side
band (PSB), red-shifted in emission. In practice, excitation into a PSB results in additional broad red shifted
emission from an inhomogeneous distribution of ZPLs.

Ultimately, the remaining source of homogeneous broadening is mainly determined by the
lifetimes of the different states involved in the transitions. The shorter the lifetime, the less precise
its energy and the broader the corresponding spectral lines will be. This so-called lifetime
broadening is a quantum mechanical effect related to Heisenberg’s uncertainty principle 6, and it
will be discussed later in this chapter.
In order to obtain a Shpol’skii spectrum the solvent should form a poly-crystalline matrix
at low temperature.
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In practice, mostly n-alkane solvents are used, but cycloalkanes are also possible. Finding
the most appropriate solvent is not always evident and may involve some trial and error. For the
analyte to fit into the poly-crystalline matrix, the three-dimensional shape, polarity, rigidity and
the number of substituents of the fluorophore are very important. Ideally, the analyte molecule
should displace a distinct number of solvent molecules in the lattice to only fit in a single, welldefined manner in the available space. In that case, all the analyte molecules will experience
exactly the same interaction with the crystalline matrix, which means that the S 0-S1 energy
differences will be identical. However, sometimes there are two or several ways in which the
molecule fits in the matrix; the molecule is said to occupy different sites (see Figure 4). For each
site the S0-S1 energy difference is likely to be different. As a result, a multiplet will appear in the
spectrum, both in absorption and emission and for every vibronic transition. In other words, two
or more identical spectra will be observed, but shifted over a small amount of energy. The intensity
ratio, which reflects the relative populations of each site, is constant for every multiplet. By using
a tuneable laser, one of these subpopulations can selectively be excited in the 0-0 transition or in
a vibration of the first excited state. Only this site will then appear in the emission spectrum.
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Figure 4. Cartoon showing the occurrence of different sites if the molecule fits in more than one way in the crystal.
The relative line intensities in the spectrum reflect the respective populations.

A laser is not strictly needed to obtain high-resolution spectra in Shpol’skii spectroscopy.
Literature reports show that high quality Shpol’skii spectra can be recorded with a standard
spectrofluorimeter equipped with a broad-band, continuous wave xenon arc lamp.8,9 The main prerequisite in Shpol’skii spectroscopy is that the solvent forms a regular poly-crystalline matrix upon
cooling. In the ideal situation, the analyte molecule displaces a distinct number of solvent
molecules in the lattice and fits in a well-defined manner in the available space thus provided.
Under excellent host-guest compatibility conditions, all solute molecules experience the same
interactions with the environment and the broadening due to matrix inhomogeneity is reduced to
about 1cm-1. As depicted in Figure 5, the resulting spectrum provides vibrational information for
“fingerprint” compound identification.
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Figure 5. Jablonski diagram illustrating the concept of Shpol’skii spectroscopy (A) and the resulting spectrum (B).
Only four vibrations are shown; in the absence of reorientation during the fluorescence lifetime.

Significant extra broadening can be observed if one of the states involved in excitation or
emission has a lifetime shorter than approximately one picosecond. The origin of this so-called
lifetime broadening is the time-energy uncertainty relationship, i.e. when the time of the transition
can be determined accurately its energy cannot and vice versa. From the broadened spectral lines
the lifetime can be calculated according to the following equation:



1
2      c

(1.8)

Where  is the lifetime of the short-living state,  the homogeneous broadening (in cm-1)
and c the speed of light (in cm/s).
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Usually, in Shpol’skii spectroscopy these effects are only observed in excitation when
higher electronic states (S2, S1 ...) are involved, since subsequent vibrational relaxation and/or
internal conversion is fast. As a result, the bands observed in the excitation and/or absorption
spectrum tend to be broader at shorter wavelengths.7, 10 that is the main reason selective excitation
is best accomplished within the S1 band.
1.3. High Molecular Weight PAHs
Recent toxicological studies attribute a significant portion of the biological activity of
PAHs contaminated samples to the presence of high molecular weight (HMW) PAH, i.e. PAHs
with MW ≥ 300. The first group of HMW PAHs, i.e. the MW 300 and MW 302 isomers, has been
identified in combustion related samples with high PAHs content such as coal tar,11-14 carbon
black,15-17 and fuel combustion exhaust.18-20 Their presence has also been confirmed in
environmental samples such as air particulate matter,13,14,21-24 mussels,614 sediments13,14,24-27 and
soils.26-28 Coronene is generally the only MW 300 isomer measured, even though a number of
other isomers are possible.18,29 Up to date, only a limited number of studies have reported the
quantification of individual isomers.12-14, 20 The majority of the reports have only been able to make
a tentative identification of individual isomers or had to report concentrations in terms of a total
fraction composed of several isomers. Because the carcinogenic properties of HMW PAHs differ
significantly from isomer to isomer, it is of paramount importance to determine the most toxic
isomers even if they are present at much lower concentrations than their less toxic isomers.
The need for unambiguous isomer identification is further intensified by recent findings
showing that some HMW PAHs can exhibit far higher carcinogenic properties than EPA-PAHs.
A crucial example is Dibenzo[a,l]pyrene (DB[a,l]P).
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This compound is the most potent carcinogenic PAHs known to date30-32. Its carcinogenic
potency is approximately 100 times higher than that of Benzo[a]pyrene (B[a]P). There are several
more isomers of dibenzopyrene - including dibenzo[a,e]pyrene (DB[a,e]P), dibenzo[a,h]pyrene
(DB[a,h]P), dibenzo[a,i]pyrene (DB[a,i]P) and dibenzo[e,l]pyrene (DB[e,l]P) (Figure 6) which
are also carcinogenic, but not to the extent DB[a,l]P is. Thus, unambiguous identification of
DB[a,l]P in environmental samples is highly relevant even if the other isomers are present at 10 to
100 times higher concentrations. Although DB[a,l]P is the most potent carcinogenic PAHs known
to man, there are only limited data on its formation and presence in the environment. Early
carcinogenicity

studies

mistakenly

used

the

relatively

weaker

carcinogen

dibenzo[a,e]fluoranthene.33 As a matter of fact, only recently the U.S. Department of Health and
Human Services listed DB[a,l]P, DB[a,e]P, DB[a,h]P and DB[a,i]P as potential carcinogens to
humans.34
Unfortunately, EPA methodology cannot always meet the challenge of specifically
analyzing structural isomers at the low concentration levels of environmental samples. The main
problems that confront EPA methodology arise from the relatively low concentration levels and
the large number of HMW PAHs isomers with very similar elution times and similar, possibly
even identical, fragmentation patterns. An important component of our research, then, focuses on
developing methods with the ability to efficiently and reliably detect the presence and determine
the amounts of the most toxic HMW PAHs, even if their less toxic isomers are present in far higher
concentrations.
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Figure 6. Molecular structure of 5 HMW-PAHs with

MW 302.

1.4. Benzo[a]pyrene and Benzo[a]pyrene Metabolites
Parent PAHs are relatively inert and need metabolic activation to express their
carcinogenicity. Covalent binding to DNA is believed to be the first critical step in the initiation
of the tumour formation process.36, 37 Complex heterogeneity makes the identification of the type(s)
of chemical lesion(s) an extremely challenging problem. For instance, a given metabolite may bind
to different bases or different nucleophilic centers of a base and exist in distinctly different adductDNA conformations.38-41 Metabolism may also lead to a distribution of stereoisomeric metabolites
and, as a consequence, stereo specific additions to DNA. The complexity of the problem is well
illustrated in Figure 7. In the initial step of the metabolic activation of B[a]P, cytochrome P450s
A1, 1A2, 1B1, 3A4, and 2C catalyze the formation of arene oxides and phenols 42-45.
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The arene oxides may arrange spontaneously to phenols or undergo hydration catalyzed by
epoxide hydrolase, leading to dihydrodiols. 7,8-Dihydro-7,8-dihydroxybenzo[a]pyrene is further
oxidized to anti- and syn-7,8-dihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE) in a reaction
catalyzed by P450s 1A1, 1A2, and 1B1, as well as other enzymes.46-48 Among the four BPDE
enantiomers produced in these reactions, the (7R,8S,9S,10R)-enantiomer of anti-BPDE is
generally formed to the greatest extent and shows the highest carcinogenic activity.46-49 This diol
epoxide reacts with DNA in vitro and in vivo, producing a major adduct in which the exocyclic
amino group of deoxyguanosine undergoes trans addition to carbon 10 of BPDE. Convincing
evidence clearly supports the hypothesis that the formation of this and related minor DNA adducts
is the major metabolic activation pathway of B[a]P

46-51

. Other pathways of B[a]P metabolism

lead predominantly to detoxification. These include phenol formation, glutathione conjugation of
arene oxides and diol epoxides involving GSTM1, GSTA1, and GSTP1, and glucuronidation of
dihydrodiols.
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Figure 7. Overview of B[a]P metabolism. CYP: Cytochrome P450.69

By virtue of the rich heterogeneous distribution of metabolic products they produce, PAHs
provide a full spectrum of the complexity associated with understanding the initial phase of
carcinogenesis. During the past decades, tremendous efforts have been made to develop bioanalytical techniques that possess the selectivity and sensitivity for the problem at hand. The
general scheme consists of metabolites separation and determination.52-54 Separation of
metabolites has been accomplished via HPLC, capillary electrophoresis (CE) and GC.
Ultraviolet –visible absorption and room temperature fluorescence detection have been
widely used with both HPLC and CE.60-65 The ultimate specificity belongs to high-resolution MS
either coupled to gas chromatography (GC-MS) or HPLC (HPLC-MS).52-54, 66-68.
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Depending on the complexity of the sample and the relative concentrations of the targeted
metabolites, a combination of preparation techniques is often necessary to reach the limits of
detection of the instrumental method of analysis.56-59 The numerous preparation steps open ample
opportunity to metabolite loss and collection of inaccurate data. This dissertation presents an
experimental approach based on solid-surface room temperature fluorescence spectroscopy.
Octadecyl-silica membranes are employed with the dual purpose of metabolite extraction and solid
substrates for spectroscopic measurements. The simplicity of the experimental procedure and the
excellent analytical figures of merit demonstrate its potential for screening biomarkers of PAH
exposure in numerous urine samples
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CHAPTER 2. LASER EXCITED TIME-RESOLVED SHPOL’SKII
SPECTROSCOPY
2.1. Introduction
Prior to our involvement with Shpol’skii spectroscopy, most of the applications towards
the analysis of PAHs were based on the interpretation of fluorescence spectra 71, 72. Although timeresolved spectroscopy had shown to reduce spectral overlapping 70, information on fluorescence
lifetimes as qualitative parameters for PAHs identification was practically inexistent. The same
was true for phosphorescence spectra and lifetimes.
One contribution we have made to this area is the introduction of methodology to
efficiently collect multidimensional data formats during the lifetime decays of fluorescence
(nanoseconds to microseconds) and phosphorescence (milliseconds to seconds) emission 73-75. Our
approach – which we have coined laser excited time-resolved Shpol’skii spectroscopy (LETRSS)
- takes advantage of the full dimensionality of luminescence spectroscopy combining spectral and
lifetime information in multidimensional formats known as wavelength time matrices (WTM).
Adding the temporal dimension to the highly resolved Shpol’skii spectra provides an extremely
selective tool for the determination of structural isomers in complex mixtures with numerous
PAHs.
We developed an instrument to collect multidimensional data formats in both the
fluorescence and phosphorescence time domains. Unambiguous isomer identification was made
possible on the bases of spectral and lifetime analysis.
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In addition to providing a qualitative parameter for PAHs identification, fluorescence
and/or phosphorescence decays report on spectral peak purity, an essential condition for the
accurate quantitative determination of PAHs without previous chromatographic separation.
Another significant improvement we made was the introduction of cryogenic fiber optic probes
for sample freezing at 77 K and 4.2 K. It is now possible to easily perform reproducible
measurements at liquid nitrogen liquid helium temperatures in a matter of seconds.
2.2. Cryogenic Fiber Optic Probes
The classic sample preparation procedure for 77 K measurements consists of immersing a
solution-filled small-diameter tube into an optical Dewar filled with liquid nitrogen. The fragility
of the Dewar flask, bubbling in the cryogen at irregular intervals from small ice particles that act
as nucleation sites, and condensation on the outside of the Dewar are nuisances. However,
scattering at each of the interfaces encountered by the excitation light on its way to the sample is
a much more severe problem, as stray light in the emission monochromator degrades the
reproducibility of measurements and the LOD. The classic approach typically involves three
air/glass interfaces, two liquid nitrogen/glass interfaces, and one matrix/glass interface. The
number of scattering interfaces can be reduced with closed-cycle refrigerators or Joule-Thomson
miniature refrigerators that employ contact cooling or cold vapor directed onto the sample cell.
Trade-offs include higher cost, reduced sample throughput, and possibly less efficient or slower
cooling of the sample. Depending on the cooling device and final temperature, and sample size
and solvent, freezing times can take between 40 and 100 min per sample. The constancy of the
freezing rate is a concern, because it can affect the population distribution in the various sites and
the corresponding signal intensity for a given set of excitation and emission wavelengths.
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Several attempts have been made to improve closed-cycle helium refrigerators. Ariese and
co-workers

70

developed a user-friendly closed-cycle refrigerator that enables the simultaneous

cooling of four 10µL samples placed in a gold-plated copper holder surrounded with sapphire
windows. The high thermal conductivity of the sample holder material provides fast sample
cooling for good quality Shpol’skii spectra.
We use fiber optic probes for cryogenic measurements at both 77 K and 4.2 K. Our probes
are similar to the one reported by Hieftje and co-workers 76 for phosphorescence measurements at
77 K. Hieftje’s probe consisted of one excitation and six emission fibers bundled in a quartz tube
with the opposite end connected to a plastic sample vial. Sample excitation and emission collection
was made through a quartz window placed between the quartz tube and the sample vial. Our probes
retain the simplicity of “dunking” the sample into the liquid cryogen for fast and reproducible
freezing, but eliminate all interfaces that could scatter excitation light into the detection system.
Figure 8A shows an example of a probe for cryogenic measurements at 4.2 K. At the sample end,
the fibers are epoxied in a six-around-one configuration with the delivery fiber in the center. At
the collection end, the excitation and collection fibers are separated and vertically aligned with the
spectrograph entrance slit. After the sample is introduced into the sample tube, the tip of the probe
is positioned above the solution surface as the sample tube is lowered into a container filled with
liquid cryogen. The cell is allowed to cool for 90 s prior to luminescence measurements to ensure
complete sample freezing. Because there is no physical contact between the fiber and the sample,
fiber clean up between samples is not necessary. Preparing frozen samples for luminescence
measurements at 77 K and 4.2 K is now a routine technique. Samples are frozen in a matter of
seconds.
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2.3. Instrumentation for Multidimensional Luminescence Spectroscopy
Pulsed excitation sources offer prospects for time-resolving the emission to improve signalto-background ratios and reduce spectral interference. Early reports on laser excited Shpol'skii
spectrometry implemented time resolution at fixed delay time intervals by using laboratoryconstructed gated integrators or commercial boxcar averagers 77-81. Later, advantage was taken of
commercially available delay generators and intensified linear photodiode arrays. Multi-channel
detectors can acquire emission spectra at good signal-to-noise ratios much faster than is possible
with scanning monochromators. Collecting the entire emission spectrum at once avoids problems
associated with pulse-to-pulse fluctuation, laser intensity drift, and photodecomposition that could
degrade analytical figures of merit.
Our group has shown that the combination of a pulsed tunable dye laser, a pulsed delay
generator, a spectrograph, and an intensifier-charged coupled device (ICCD) is well suited for the
rapid collection of WTMs, excitation-emission matrices (EEMs) and time resolved EEMs
(TREEMs) in both the fluorescence and the phosphorescence time domains. Figure 8B shows a
schematic diagram of the instrumental set-up mounted in our lab. As an excitation source, we have
used a compact frequency doubled pulsed tunable dye laser whose bandwidth (< 0.03 nm) is well
matched for selective excitation of narrow Shpol'skii excitation spectra. The ICCD is coupled to a
spectrograph to rapidly collect a series of emission spectra at different delay times between the
laser firing and the opening of the gate on the ICCD. The integration of the mechanical shutter in
the path of the dye laser excitation beam facilitates the collection of multidimensional data in the
phosphorescence time domain.

21

The shutter has a rise time (open time) of 1.5 ms and a fall time (close time) of 3.0 ms with
a maximum pulse width of 6.5 ms. The shutter is controlled either manually (always open or
always closed) via a switch on the controller front panel or programmatically through a transistortransient logic (TTL) pulse. This TTL pulse is programmed through the A + B outputs of the digital
delay generator via a general purpose interface bus (GPIB) interface.
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Figure 8. Instrumental system and fiber optic probe for 4.2 K laser-induced fluorescence spectrometry with single
channel and multi-channel fluorescence detection.
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Fluorescence measurements are made with the mechanical shutter in the open position.
Time resolution is achieved with the intensifier in front of the ICCD, which acts as a superfast
shutter with a minimum gate of 2 ns (full width at half-maximum). Once triggered by the laser,
the pulse delay generator uses this information to determine when the image intensifier in the
detector head is gated on (gate delay, D) and for how long it is gated on (gate width, G). These
parameters are entered on the control computer with commercial software. The ICCD acquires
data while the intensifier is gated on. While the intensifier is gated off, the acquired data are
transferred from the detector head to the controller card (32-bit Intelligent Bus-Mastering PCI
card) in the computer. Typically, fluorescence spectra from PAHs result from the accumulation of
emission of 100 laser pulses. This process takes approximately 10 ms/40 nm spectrum. If a
wavelength range larger than 40 nm is of interest, the spectrograph is tuned to the new wavelength
range and the process is repeated.
Previous reports on WTM collection utilized a rather tedious and time consuming
procedure, in which the wavelength of either the laser source or the emission monochromator was
incremented while the luminescence intensity-luminescence decay waveform was collected at
each wavelength. By setting the ICCD gate step parameter, our system automatically increments
the time interval between successive fluorescence scans so that a WTM is easily built up. The
duration of the steps by which the gate delay is progressively increased in the course of the
sequence of acquisitions is entered on the control computer with commercial software.
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Fluorescence lifetimes are recorded via a three-step procedure: (1) full sample and
background WTM collection; (2) Background decay curve subtraction from the fluorescence or
phosphorescence decay curve at a wavelength of maximum emission for each PAH; and (3) fitting
of the background corrected data to single-exponential decays. Commercial software is used for
curve fitting of fluorescence and phosphorescence lifetimes. Fitted decay curves y = y0 + A1e[-(xx ))t ]
0 1

are obtained by fixing x0 and y0 at a value of zero.

2.4. Multidimensional Data Formats from Single-Site and Multi-Site PAH/N-Alkane
Systems
The experimental value (0.09 nm) of the full width at half maximum for a mercury (Hg)
line (313 nm) emitted from a Hg lamp placed at the analysis end of the fiber optic probe is within
the theoretical value calculated from the spectral range of an individual pixel in the CCD array.
Based on the reciprocal linear dispersion (RL = 0.8 nm/mm) of the spectrograph, the number of
active pixels (690 x 256) in the array, and the dimensions (18 x 6.7 mm) of the active area of the
CCD chip, the spectral range of one pixel should give a 0.02 nm limiting resolution. Because of
the detector crosstalk and the intensifier, the factual limiting resolution corresponds to 4-5 pixels
(5), i.e. 0.08 - 0.10 nm. This resolution is sufficient to collect accurate spectra from both singlesite and multiple-site PAH/n-alkane systems. Figure 9 shows an example of a single-site
(naphthalene in n-pentane) multiple-site system, i.e. benzo[a]pyrene in n-octane. Upon fast cooling
in n-heptane, benzo[a]pyrene occupies four crystallographic sites that yield four distinct
fluorescence spectra slightly shifted by small wavelength differences.
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The maximum wavelengths of the quartet emissions from the 0-0 transitions appear at
402.3, 402.7, 403.1 and 403.8 nm. The maximum wavelengths and the relative intensities of the
fluorescence peaks correlate well to those previously reported with conventional methodology 7072

.
Figure 10 shows two WTMs recorded with the fiber optic probe at 77 K along with their

respective If vs. td plots.
The gate delay (td) was advanced in 20 ns increments for pyrene and 5 ns increments for
dibenz[a,h]anthracene. The fluorescence spectrum at each gate delay td was averaged over 100
laser pulses. Table 1 summarizes the lifetimes of the 6 PAHs obtained by this procedure. In all
cases, single exponential decays were observed. The agreement between the calculated and
observed points over the first two lifetimes of the decay is within about 1% and the residuals show
no systematic trends. Background emissions from n-alkanes have relatively short lifetimes (~ 5
ns). With long-lived compounds, such as benzo[g,h,i]perylene (183 ns) and pyrene (527 ns), the
collection of strong PAH fluorescence can start at relatively long delay times (td > 30 ns), in which
case the main contribution to the background is instrumental noise. For PAHs with shorter
fluorescence lifetimes, such as dibenz[a,h]anthracene (41 ns), complete time-resolution of
fluorescence background is not possible, but the td and gate time (tg) values can be selected to
collect most of the fluorescence emitted by the PAH.
Interesting to note are the significant lifetimes differences we have observed from PAHs
molecules occupying different crystallographic sites in the same matrix. Some examples are
summarized in Table 1.
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No other reports exist on this phenomenon but our observations are consistent with the
well-known sensitivity of fluorescence lifetimes to the microenvironment of the fluorophore. It is
generally accepted that the multiplet structure of fluorescence spectra arise from the different
orientations of the PAH molecule in the solid matrix. The different orientations lead to nonequivalent crystal field effects and hence wavelength shifts 89, 90. Most likely, the field effects are
also sensed by the PAH fluorescence lifetime. The lifetime differences from site to site are usually
larger than their wavelength shifts.
This fact helped us to identify the two crystallographic sites of benzo[a]pyrene in n-octane,
which had been previously reported as a single site system. Although we have not unfolded the
analytical potential of site selective lifetime analysis yet, the rather large lifetime differences
anticipate a promising contribution to enhancing the specificity of site-selective excitation. As we
will later show in this review, the specificity of lifetime measurements plays an important role in
the analysis of closely related structural isomers.
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Figure 9. 4.2 K fluorescence spectrum of 10 µg mL-1 naphthalene in n-pentane (top) and 0.2 µg mL-1 benzo[a]pyrene in n-heptane (bottom)
recorded with the fiber-optic probe, spectrograph, and ICCD camera. The naphthalene spectrum was recorded with an excitation wavelength of 306.0 nm,
spectrograph entrance slit of 42 µm, delay of 10 ns and a gate of 1000 ns. The benzo[a]pyrene spectrum was recorded with an excitation wavelength of
366.0 nm, spectrograph entrance slit of 25 µm, delay of 20 ns and a gate of 200 ns. Both spectra correspond to the accumulation of 100 laser shots.
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Figure 10. 77 K WTMs recorded from 1 µg mL-1 standards of (A) pyrene and (B) dibenz[a,h]anthracene in n-hexane. The following acquisition
parameters were used for spectra collection: (A) λexc = 280 nm, td = 10 ns, tg = 200 ns and gate step = 20 ns; (B) λexc = 290 nm, td = 10 ns, tg = 200 ns and gate
step = 5 ns. Each fluorescence spectrum in the WTMs corresponds to the accumulation of 100 laser pulses. Entrance slit of spectrograph was 100 µm.
Fluorescence decays of pyrene (C) and dibenz[a,h]anthracene (D) built with fluorescence intensities stripped from the WTMs at the maximum wavelengths of
emission.
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Table 1 Fluorescence lifetimes (τ) of PAHs molecules occupying different crystallographic sites in the frozen matrix
n-hexane

n-heptane

n-octane

λemb (nm)

τ (ns)

λemb (nm)

τ (ns)

λemb (nm)

τ (ns)

Benzo[a]pyrene

403.56
403.94
404.53

27.02 ± 0.50
43.44 ± 1.00
31.95 ± 0.89

402.31
402.72
403.15
403.89

52.09 ± 0.93
46.93 ± 0.49
42.77 ± 0.89
41.29 ± 1.18

403.10
403.20

36.04 ± 0.61
45.68 ± 0.84

Pyrene

376.63
372.45

503.98 ± 6.01
577.43 ± 3.47

--------c

--------c

--------c

--------c

Benzo[a]anthracene

383.34
383.94

53.63 ± 0.50
56.43 ± 0.76

--------c

--------c

--------c

--------c

PAHa

a

PAHs solutions were prepared at 0.5 µg mL-1.
b
Wavelength of maximum fluorescence emission. All data obtained using λexc = 288.50.
c
Spectra and decay data were not measured for this PAH/solvent system.
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Recording two-dimensional (2-D) fluorescence spectra – i.e. plots correlating fluorescence
intensities to emission wavelengths - from a mixture with numerous fluorescence components only
provides partial information on the total fluorescence of the sample. The emission profile of a
mixture with numerous fluorescence components varies with the relative position of the excitation
wavelength to the excitation maxima of the fluorophores in the mixture. Individual fluorophore
contributions to the total fluorescence spectrum of the sample also depend on the fluorescence
quantum yields of the fluorophores and possible quenching due to synergistic effects. EEM gather
all this information in a single data format to provide a true signature of the total fluorescence of
a multi-fluorophore mixture.
Most of the work on low-temperature EEM has been performed with high-resolution
spectrometers that built up fluorescence EEM with numerous repetitive scans

70

. The main

drawbacks of this approach are the long EEM acquisition times, the need for relatively large
excitation and emission bandwidths and the inability to record phosphorescence EEM. The large
bandwidths, which are imposed by the low throughput of the high-resolution spectrometers, limit
the spectral resolution of the EEM and the selectivity of analysis.
Our system is well suited for rapid collection of low-temperature fluorescence and
phosphorescence EEM. Because of the spectrograph and the ICCD, both formats are collected in
short analysis time. The tunable dye laser provides intense excitation energy in a narrow excitation
bandwidth. Its scanning capability is essential to take full advantage of the specificity obtainable
from the highly resolved PAH excitation spectra in Shpol’skii matrixes. Its intense excitation
energy promotes strong PAH fluorescence to recording spectra with optimum spectrograph slits
for maximum spectral resolution.
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Figure 11 displays the 4.2 K fluorescence and phosphorescence EEM of chrysene in noctane. The dye laser was automatically tuned in 0.1 nm steps between 310 and 335 nm. Collecting
the entire fluorescence and phosphorescence data sets took no longer than 5 and 8 min,
respectively. Both EEM show similar features shifted from each other with regards to emission
wavelengths. This pattern is often an indication that multiple sites are present in the frozen matrix.
Our lifetime measurements (see Table 1) confirm this multiple structure of fluorescence and
phosphorescence emission.
In comparison to EEM, chemical analysis based on TREEM is potentially more selective
because it adds the temporal dimension to the orthogonal spectral dimension of EEM. TREEM are
basically a series of fluorescence WTM acquired at different excitation wavelengths.
The complete data set consists of fluorescence intensity as a function of excitation
wavelength, emission wavelength, and delay time after the short duration of pulse excitation. All
the intensity values (as a function of excitation and emission wavelengths) for a particular decay
time can be assembled into an EEM format specific for that decay time.
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Figure 11. 4.2 K fluorescence and phosphorescence EEM recorded from a 0.2 µg mL -1 chrysene solution in
n-octane. The fluorescence EEM was recorded using a 20 ns delay and a 200 ns gate time. The phosphorescence
EEM was collected using 10 µs delay and 40 ms gate times. The excitation wavelength step was 0.1 nm.
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The potential of TREEM is here illustrated with the direct determination of DB[a,l]P in a
heavily contaminated water sample from the American Petroleum Institute (API). API water is
used to desalt and scrub crude oil and oil fractions in the refinery process and shows a visible
surface petroleum layer at the separator trough. Previous HPLC analysis of this water has shown
heavy contamination with fluorescent pollutants, including several EPA-PAHs. The complexity of
this sample is illustrated in Figure 12 with the UV-VIS chromatogram of the sample extract and
the 4.2 K EEMs collected within the wavelength ranges of DB[a,l]P. At the top EEM, the delay
(10 ns) and the gate (1000 ns) were selected to collect a substantial portion of the total fluorescence
of the sample. The low-intensity features throughout most of the EEM indicate extensive
fluorescence background from several concomitants in the sample. The bottom EEM was collected
after spiking the API water with DB[a,l]P at the 0.5 ng mL-1 concentration level. Because the delay
(10 ns) and the gate (250 ns) were optimized to enhance the spectral features of DB[a,l]P, the
fluorescence background disappears and the presence of DB[a,l]P is clearly noted.
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Figure 12. (A) Chromatogram of API water extract using Supelcosil LC-PAH column. (B) 4.2 K EEM of API water
recorded from an extraction membrane spiked with 100 µL of n-octane. Delay and gate times were 10 and 1000 ns,
respectively. (C) 4.2 K EEM of API water spiked with 5 ng mL -1 DB[a,l]P prior to SPE. EEM was recorded from an
extraction membrane spiked with 100 µL of n-octane. Delay and gate times were 10 and 150 ns, respectively. In
both cases, spectra were accumulated over 100 laser shots at each excitation wavelength using increments of 0.2 nm.
Spectrograph slits were 42 µm.
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2.5. LLE-LETRSS and SPE-LETRSS
The use of cryogenic fiber optic probes facilitates the hyphenation of LETRSS to sample
pre-concentration techniques for the analysis of aqueous samples. LLE-LETRSS and SPELETRSS methods have been developed in our lab for the determination of polycyclic aromatic
compounds in HPLC fractions and sample extracts

83-88

. Figure 13A shows the main steps of the

experimental procedure for LLE-LETRSS. Millilitre volumes of aqueous sample are mixed with
micro-litters of Shpol’skii solvent (n-alkane) in the vessel of the fiber optic probe. After shaking
the vessel for 1-2 min, the mixture is allowed to stand for ~ 1 min to separate the two liquid layers.
The sample vial is then attached to the optical probe and the fiber assembly is lowered into
the liquid cryogen for LETRSS measurements. Quantitative analysis is based on the linear
relationship that exists between analyte concentration in the Shpol’skii layer (CSS) and its
concentration in the aqueous sample (CAS):
CAS = (1/Kd) x (VSS/VAS) x CSS

(2.1)

Where Kd is the partition coefficient of the analyte between the Shpol’skii solvent and the aqueous
sample (Kd = CSS/CAS), and VSS and VAS are the volumes of Shpol’skii solvent and aqueous sample,
respectively.
Two different procedures have been developed for SPE-LETRSS analysis. Figure 13B
depicts the main steps of the eluting method. A 13 mm octadecyl (C-18) membrane is placed into
a 100 mL extraction syringe. Positive pressure is used to force all liquid solutions through the disk.
Prior to sample extraction, the C-18 membrane is conditioned with 1 mL of methanol.
Following water extraction, void water is mechanically removed by forcing three 100 mL
volumes of air through the disk.
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PAHs are eluted from the extraction membrane using an appropriate volume of Shpol’skii
solvent. The quantitative correlation between the PAHs concentration in the aqueous sample and
the layer of Shpol’skii solvent is given by the following equation:
CAS = [f2/f1] x [VSS/VAS] x CSS

(2.2)

Where f1 and f2 are the fractions of extracted and eluted PAHs, respectively. For a 10 mL
sample volume (VAS = 10 mL) and 5 mL of eluting solvent (VSS = 5 mL), the best sample preconcentration factor ([f2/f1] x [VSS/VAS]) that one could obtain would be 2, i.e. when f1and f2 are
both equal to 1. Table 2 summarizes f1 and f2 values of several EPA-PAHs. The amounts of
extracted PAHs are statistically equivalent to 100% (P = 0.05; N = 6), i.e. f1 = 1. The same is not
true for the f2 values of some PAHs. Two factors are known to deteriorate PAHs recovery from
extraction membranes: (a) non-reversed-phase interactions (hydrogen bonding and dipole-dipole
interactions) between the PAH and the unreacted (residual) silanol and siloxane groups on the
surface of octadecyl silica phases; and (b) the presence of trapped and sorbed water in the silica
particles. The strength of hydrogen bonding and dipole-dipole interactions varies with the
physico-chemical properties of the PAH, which might explain some of the variations in recoveries.
The air-drying procedure prior to PAH elution removes the majority of the water in the void
volume. The water in the smallest pores (trapped water) and water sorbed to the silica surface
remains on the membrane. This water possibly blocks the interaction between n-alkane and the
PAH, deteriorating the extraction efficiency of the non-polar solvent.
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Table 2 Solid-Phase Extraction of EPA-PAHs
PAH
Naphthalene
Acenaphthene
Fluorene
Phenanthrene
Anthracene
Fluoranthene
Pyrene
Benzo[a]anthracene
Chrysene
Benzo[b]fluoranthene
Benzo[k]fluoranthene
Benzo[a]pyrene
Dibenz[a,h]anthracene
Benzo[g,h,i]perylene
Indeno[1,2,3-cd]pyrene
a
b

f1 a

f2

0.994 ± 0.003
0.999 ± 0.016
0.988 ± 0.023
0.997 ± 0.030
0.999 ± 0.005
0.999 ± 0.020
0.999 ± 0.019
0.998 ± 0.021
0.997 ± 0.018
0.994 ± 0.034
0.954 ± 0.063
0.949 ± 0.083
0.723 ± 0.040
0.959 ± 0.082
0.929 ± 0.038

b

0.578 ± 0.035
0.551 ± 0.016
0.534 ± 0.039
0.571 ± 0.064
0.103 ± 0.033
0.937 ± 0.061
0.992 ± 0.022
0.969 ± 0.014
0.105 ± 0.065
0.883 ± 0.056
0.977 ± 0.035
0.574 ± 0.076
0.104 ± 0.048
0.588 ± 0.026
0.889 ± 0.018

Based upon fluorescence of PAH solution before and after extraction.
Determined by standard additions on eluent.
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Better pre-concentration factors are obtained with the spiking method. The main steps of
the spiking procedure are shown in Figure 13C. The 5.5 mm diameter allows for the membrane to
fit into the vessel of the fiber optic probe (~ 6 mm inner diameter). Quantitative analysis obeys the
following equation:
CAS = (VSS/f1VAS + KVM/f1VAS) x CSS

(2.3)

where K is the distribution ratio between the analyte concentration on the membrane (CM)
and in the Shpol’skii solvent – i.e., K = CM/CSS - and VM is the volume of the extraction membrane,
i.e. 23.8 µL. VM is calculated using the standard formula for the volume of a cylinder V = πr2h,
where r is the radius of the membrane (2.75 mm) and h is its thickness (~ 1 mm).

Figure 13. Schematic diagram of the experimental procedures for (A) LLE-LETRSS, (B) eluting SPE-LETRSS and
(C) spiked SPE-LETRSS for the analysis of aqueous samples.
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For phenanthrene (K = 3.3 ± 0.41), chrysene (K = 10.80 ± 2.50) and fluorene (K = 8.0 ±
1.4), 10 mL of water sample (VAS = 10 mL; f1= 1) and 100 µL of n-hexane (VSS = 100 mL),
equation (3) predicts pre-concentration factors ranging from ~ 34 (fluorene) to ~ 79 (chrysene).
The spiking method is particularly useful for the analysis of polychlorinated biphenyls (PCBs) and
polychlorinated dibenzofurans (PCDBFs). PCBs and PCDBFs show strong phosphorescence
emission in Shpol’skii matrixes at both 77 K and 4.2 K. Many cases exist where the amount of
eluted PCB or PCDBF behaves randomly and makes SPE unsuited for analytical use. In other
cases, the low amount of eluted PCB or PCDBF provides poor analyte recoveries. In our lab, the
worst-case scenario was observed with 4-chlorobiphenyl, which had a zero recovery from the
extraction membrane. Table 3 summaries the K values for biphenyl, dibenzofuran, three PCBs and
three PCDBFs obtained with 100 μl of n-heptane. The tabulated values were obtained from the
slopes of the CSS vs. CM plots. The standard deviations of the slopes were calculated via the
bivariate least-squares regression method, which takes into account the uncertainties in both axes
of the CSS vs. CM plots

91, 93

. The variances close to unity show the linear relationships between

CSS and CM and the constant slopes demonstrate that K remains the same within the studied
concentration range. The K values demonstrate the highest affinity of 4-chlorobiphenyl for the
extraction membrane, which correlates well to the zero percent recovery of the eluting procedure.
It is also interesting to note that the distribution ratio of biphenyl (K = 9.78) is lower than the K
values of the three PCBs. The same is true for dibenzofuran (K = 4.08) and the three PCDBFs.
The higher affinity of the chlorinated pollutants for the membrane can be attributed to nonreversed-phase interactions (hydrogen bonding and dipole–dipole interactions) with the unreacted
(residual) silanol and siloxane groups on the surface of octadecyl silica phases.
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Although hydrogen bonding and dipole–dipole interactions might also occur with
biphenyl and dibenzofuran, the presence of chlorine atoms possibly enhances their effect.

Table 3 Distribution ratios of organic pollutants between SPE membrane and Shpol’skii solvent

Analyte
Dibenzofuran
Biphenyl
2-Chlorodibenzofuran
2,8-Dichlorodibenzofuran
2,3,7,8Tetrachlorodibenzofuran
4-chlorobiphenyl
3,3’,4,4’-Tetrachlorobiphenyl
2,3’,4,4’,5-Pentaclorobiphenyl

Ka

Sb

4.08
9.78
7.34
24.75
9.33
133.84
13.42
24.58

0.45
0.88
0.55
3.16
0.10
16.32
2.21
3.11

a

K, distribution ratio defined as K = CM/CSS. Where CM is the analyte concentration in the SPE
membrane and CSS is the analyte concentration in the organic solvent.
b
S = standard deviation of the slope (K). K and S were obtained from linear regression plots.91

Despite the rather large K values, the analysis of PCBs and PCDBFs with the spiking
procedure is still possible. Table 4 summaries the analytical figures of merit (AFOMs) obtained
with 10 mL of water and 100 μL of n-heptane. The correlation coefficients (R) of the calibration
curves are close to unity, the linear dynamic ranges (LDR) extend over two orders of magnitude
and the limits of detection (LODs) are at the parts-per-billion level. The relative standard
deviations (RSD) measured at medium concentrations within the LDR are lower than 10%, which
is excellent for fluorescence measurements. It is important to note that the RSD represent the
precision of the method and include the random errors propagated from water extraction to signal
measurements. It is also important to note that the spiking method makes the analysis of 4chlorobiphenyl feasible.
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Table 4 4.2 K LETRSS analytical figures of merit of PCBs and PDBFs on SPE spiked with Shpol’skii solvent

R2 c

Analytea

λexc/λemb
(nm)

LDRd
(ng mL-1)

LODe
(ng mL-1)

RSDf
(%)

2-Chlorodibenzofuran
2,8-Dichlorodibenzofuran
2,3,7,8-Tetrachlorodibenzofuran
4-chlorobiphenyl
3,3’,4,4’-Tetrachlorobiphenyl
2,3’,4,4’,5-Pentaclorobiphenyl

284/440
284/434
284/440
284/482
284/494
284/491

0.9984
0.9998
0.9987
0.9996
0.9996
0.9998

0.27-150
0.85-200
0.76-200
12.8-2000
5.3-1000
5.5-2000

0.27
0.85
0.76
7.7
5.3
5.5

9.1
8.4
7.7
7.2
8.8
6.4

Analytical figures of merit were obtained with 10 mL of aqueous standard solution. 100 µL of n-heptane as Shpol’skii
solvent were used to spike the SPE membrane.
b
Excitation (λexc) and phosphorescence (λem) wavelengths.
c
R, correlation coefficient of the calibration curve.
d
LDR, linear dynamic range estimated from the limit of detection to the upper linear concentration.
e
LOD, limit of detection calculated from equation LOD = 3SB/m, where SB is the standard deviation of the blank based on 16
measurements and m is the slope of the calibration curve based on five concentrations within the LDR.
f
RSD, relative standard deviation from three sample measurements at medium concentration within LDR.
a
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CHAPTER 3. DETERMINATION OF HIGH-MOLECULAR WEIGHT
POLYCYCLIC AROMATIC HYDROCARBONS IN HIGH
PERFORMANCE LIQUID CHROMATOGRAPHY FRACTIONS OF COAL
TAR STANDARD REFERENCE MATERIAL 1597A VIA SOLID-PHASE
NANOEXTRACTION AND LASER-EXCITED TIME-RESOLVED
SHPOL’SKII SPECTROSCOPY
3.1. Introduction
Standard reference material (SRM) 1597 is a natural complex sample from Coal Tar originally
issued by the National Institute of Standards and Technology (NIST) in 1987

94

. The Certificate

of Analysis for the original SRM 1597 included 12 certified concentrations of PAHs along with
18 noncertified (reference) concentrations that included PAHs and other polycyclic aromatic
compounds. Information on the certified concentrations was obtained with a combination of gas
chromatography-flame ionization detection (GC/FID) and HPLC-fluorescence detection (HPLCFL). Noncertified concentrations assignments were solely based on GC/FID.
Since then, SRM 1597 has found widespread and continued use within the analytical
community for the validation of methods in environmental matrices. In addition to the compounds
included in the original Certificate of Analysis, this SRM has been used to develop methods for
the determination of polycyclic aromatic sulfur heterocycles (PASHs)

95,96

.PAHs of molecular

mass (MM) 278, 300 and 302 Da 94,97-98, methyl substituted benzo[a]pyrene isomers 99,106,108, other
methyl and dimethyl-substituted PAHs 100, stable carbon isotope values and radiocarbon content
of individual PAH 101, and to investigate the effects of complex PAH mixtures on the activation of
carcinogenic PAHs to DNA-binding derivatives and carcinogenesis 102-104.
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To address the need for updating the original certified values and expanding the number of
PAHs with assigned values, NIST re-analyzed SRM 1597 and reissued it as SRM 1597a

105

. Its

Certificate of Analysis included certified concentrations for thirty-four PAHs and reference values
for an additional 36 PAHs and 10 PASHs. PAH concentrations were assigned based on results
obtained with a combination of GC/MS and reversed-phase HPLC-FL. PASHs concentrations
from gas chromatography/mass spectrometry (GC/MS) and reversed-phase LC-FL. PASHs
concentrations were determined based on gas chromatography/mass spectrometry (GC/MS) and
reversed-phase LC-FL. PASHs concentrations were determined based on GC/MS and GC with
atomic emission detection (GC/AED). 95
This chapter deals with the determination of PAH isomers with MM 302 Da in SRM 1597a.
NIST has identified a total of 23 HMW-PAHs with a MM 302 in SRM 1597a 105. The assignment
of mass fraction values for 17 of these HMW-PAHs was based on the analytical approach shown
in Figure 14. In methods I – III, the coal tar sample was fractionated by normal phase-LC (NPLC)
using a semi-preparative aminopropylsilane (NH2) column that isolated isomeric fractions prior to
PAHs determination via HPLC-FL or GC/MS. HPLC separation was carried out with a silica
modified stationary phase (C18).
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Figure 14. Schematic diagram of the 5 analytical methods listed in the certificate of analysis of SRM1597a for
determining the mass fraction values for HMW-PAHs. EVAP = evaporation.

GC separation was accomplished using fused silica capillary columns with one of two
stationary phases, namely 5% phenyl-substituted methylpolysiloxane (DB-5ms) or 50% phenylsubstituted methylpolysiloxane (DB-17ms). DB-17ms was also used as the stationary phase in
GC/MS methods IV and V to attempt isomers determination without previous sample
fractionation.
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Herein, DB[a,e]P, DB[a,i]P, DB[a,h]P and N[2,3-a]P were selected to evaluate the potential
of LETRSS for the analysis of dibenzopyrenes in HPLC fractions of SRM 1597a extracts. The
advantages of using solid-phase nanoextraction (SPNE)

114,118-124

for HPLC-fraction pre-

concentration are supported with excellent analytical figures of merit. The accuracy of HPLCSPNE-LETRSS is with dibenzopyrene concentrations statistically equivalent to NIST certified
values.
3.2. Experimental
3.2.1. Chemicals and reagents
Nanopure water from a Barnstead Nanopure Infinity water system was used throughout. 20
nm average diameter gold nanoparticles (Au NPs) in aqueous solutions (7 x 1011 particles mL-1)
were purchased from Ted Pella, Inc. (Redding, CA). HPLC grade methanol and acetonitrile was
purchased from Fisher Scientific (Pittsburg, PA). Analytical grade 1-pentanethiol, toluene, noctane, n-nonane and n-decane were purchased from Acros Organics (Atlanta, GA). DB[a,l]P,
DB[a,e]P, DB[a,h]P and DB[a,i]P were purchased from Accustandard at their highest available
purity (100%). N[2,3-a]P was acquired from Sigma-Aldrich (Milwaukee, WI) at 98% purity. The
SRM 1597a extract was prepared by NIST (Gaithersburg, MD) according to an experimental
procedure reported previously 126. Briefly, 36 g of the coal tar sample were processed through an
open LC column containing attapulgus clay to remove the highly polar constituents in the sample.
The column was eluted with approximately 7 L of 10% methylene chloride in n-pentane and the
eluent was collected, evaporated and re-dissolved in 4.5 L of toluene. These quantity values were
found to extract a large fraction of PAHs from the original coal tar sample.
Note: use extreme caution when handling PAHs that are known to be extremely toxic.
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3.2.2. Pre-concentration of HPLC fractions
HPLC fractions were pre-concentrated via evaporation (EVAP) and SPNE. The SPNE
procedure has been described in detail previously 122-125. Briefly, aliquots of HPLC fractions were
mixed with 1 mL of 20 nm gold nanoparticles (Au NPs). The mixture was shaken for 5 min at
1400 rpm and centrifuged for 10 min at 13,400 rpm. The supernatant was separated from the
precipitate with a micro-pipette. 2 µL of 1-pentanethiol, 48 µL of methanol, and 50 µL of n-alkane
(n-octane, n-nonane, or n-decane) were added to the precipitate. The new mixture was shaken for
5 min at 1400 rpm. The n-alkane was removed with a micro-pipette and analyzed via 4.2 K
LETRSS. The EVAP procedure involved drying the HPLC fractions under a gentle stream of ultrahigh pure nitrogen and then re-dissolving them in 400 µL of n-alkane for 4.2 K LETRSS analysis.
3.2.3. Ultraviolet-visible absorption spectroscopy
Absorbance spectra were recorded with a single-beam spectrophotometer (model Cary 50,
Varian) equipped with a 75-W pulsed xenon lamp, 2-nm fixed bandpass, ± 0.1 nm wavelength
precision, and 24 000 nm min-1 maximum scan rate. All measurements were made with a 600 µL
quartz cuvette with a 1 cm path length.
3.2.4. Room temperature fluorescence spectroscopy
Steady-state excitation and fluorescence spectra were acquired with a commercial
spectrofluorimeter (Photon Technology International). The excitation source was a continuous
wave 75-W xenon lamp with broadband illumination from 200 to 2000 nm. The excitation and
emission monochromators had the same reciprocal linear dispersion (4 nm mm-1), accuracy (± 1
nm), reproducibility (± 2 nm) and spectral resolution (0.25 nm).
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Both gratings had 1200 grooves/nm and were blazed at 300 nm (excitation) and 400 nm
(emission). Detection was made with a photomultiplier tube (model 1527) with spectral response
from 185 to 650 nm. Instrument control was carried out with commercial software (Felix32)
specifically designed for the system. Excitation and emission spectra were corrected for
wavelength dependence of excitation light source and detector sensitivity, respectively. Correction
was made in the post-acquisition mode using the radiometric correction factors included in Felix32
software. Long pass filters were used when necessary to eliminate second-order emission from the
excitation source. Room-temperature measurements were made from un-degassed solutions in 600
µL quartz cuvettes with 1 cm optical path length. 77 K measurements followed the classical
procedure of immersing an un-degassed sample solution in a quartz tube into a nitrogen-filled
Dewar flask. The length of the quartz tube (25 m) and the design of the Dewar allow for samples
to be analyzed without any interference from condensation. Condensation occurs at the top of the
Dewar but the sample is analyzed at the bottom section of the quartz tube.

A 90 o

excitation/emission configuration was used in all measurements
3.2.5. HPLC Instrumentation
HPLC analysis was performed using a computer-controlled Hitachi (San Jose, CA) HPLC
system equipped with a (model L-7100) gradient pump, an (L-7400 UV) detector, and (L-7485)
fluorescence detector, an online degasser (L-761) and a (D-7000) control interface. Separation was
carried out on a Supelco (Bellefonte, PA) Supelcosil TM LC-PAH column with the following
characteristics: 15 cm length, 4 mm diameter, and 5 µm average particle diameters. All sample
injections were held constant at 20 µL using a fixed-volume injection loop.
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HPLC fractions were collected in 7.0 mL amber sample vials with the aid of a Gilson fraction
collector (model FC 20313).
3.2.6. Instrumentation for 4.2K LETRSS
Measurements were carried out with the multidimensional luminescence system described
previously in section 2.3 of this dissertation.
3.2.7. Sample freezing procedures
4.2 K fluorescence measurements were carried out with the cryogenic fiber optic probe and
the freezing procedure described in chapter 2.2.
3.3. Results and Discussion
3.3.1. HPLC analysis of SRM 1597a for HMW-PAHs
Previous work reported by Wise et al. demonstrated the ability to separate 12 isomers of MM
302 – including – from an SRM 1597 extract using a polymeric C18 column

94

. Separation was

achieved using a 100% acetonitrile mobile phase, a flow rate of 1.5 mL min-1 and a column
temperature of 29 oC. Figure 15A shows a typical fluorescence chromatogram of a standard
mixture of DB[a,l]P, DB[a,e]P, DB[a,i]P, N[2,3-a]P and DB[a,h]P in toluene recorded in our lab
under similar chromatographic conditions. With the exception of the 29 o C column temperature,
which we had no instrumental capability to reproduce, the chromatographic conditions were the
same as those reported previously 94.
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At room temperature, the separation of the five isomers was achieved in 40 min of analysis
time. Fluorescence detection used the following time-programmed excitation/emission
wavelengths: 0.0 min, 316/424; 10.0 min, 303/398; 20.0 min, 394/434; 29.3 min, 332/460; and
33.0 min, 313/447.
All excitation and emission wavelengths corresponded to the maximum values obtain from
pure standard spectra in 100% acetonitrile (see spectra in appendix A). Three chromatographic
runs of the same standard mixture recorded from three independent injections of 20 μL aliquots
provided the following average retention times (min): 8.89 ± 0.02 (DB[a,l]P), 12.8 ± 0.06
(DB[a,e]P), 28.5 ± 0.23 (DB[a,i]P), 30.0 ± 0.25 (N[2,3-a]P) and 35.6 ± 0.29 (DB[a,h]P). Figure
15B shows the fluorescence chromatogram of the SRM 1597a sample diluted with toluene to a
ratio that provided concentrations of DB[a,l]P (19.5 µg L-1), DB[a,e]P (157.3 µg L-1), DB[a,i]P
(67.0 µg L-1), N[2,3-a]P (74.3 µg L-1) and DB[a,h]P (44.5 µg L-1) identical to those from the pure
standards. The complexity of the coal tar sample can be clearly noticed by the large number of
chromatographic peaks. Comparison of fluorescence intensities to those in Figure 15A, suggests
potential overlapping of co-eluted peaks that could result in the inaccurate determination of the
targeted isomers via HPLC analysis.
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Figure 15. (A) Fluorescence chromatogram of a synthetic mixture containing (1) DB[a,l]P at 19.4 µg L-1,
(2) DB[a,e]P at 157.3 µg L-1, (3) DB[a,i]P at 67.0 µg L-1, (4) N[2,3-a]P at 74.3 µg L-1 and (5) DB[a,h]P at 44.5 µg
L-1. These concentrations match the certified concentrations reported for the HMW-PAHs in the certificate of
analysis for SRM 1597a. The mobile phase was 100% acetonitrile and a flow rate of 1.5 mL min-1. Excitation and
emission wavelengths were as follows: 316/424 nm (DB[a,l]P), 303/398 nm (DB[a,e]P), 332/465 nm (DB[a,i]P and
N[2,3-a]P), and 313/447 nm (DB[a,h]P). (B) Fluorescence chromatogram of the SRM 1597a using the same
conditions in Figure 15A.

3.3.2. 4.2 K LETRSS analytical figures of merit
Figure 16 shows the molecular structures of the 23 isomers with molecular mass of 302 Da
previously identified by NIST in the SRM 1597a. For the specific case of the 5 targeted isomers,
the host - guest molecular length matching criterion for best spectral resolution 122-127 leads to one
of the following three n-alkanes: n-octane (DB[a,l]P and DB[a,e]P), n-nonane (DB[a,i]P), and ndecane (N[2,3-a]P and DB[a,h]P).
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As shown in Figures17-21, these three solvents provide excitation and fluorescence
spectra with vibrational features commonly observed in 77 K Shpol’skii spectroscopy. Sample
excitation with our tunable dye laser at the maximum excitation wavelength of each isomer – i.e.,
321 nm (DB[a,l]P), 307 nm (DB[a,e]P), 398 nm (DB[a,i]P, 336 nm (N[2,3-a]P) and 314 nm
(DB[a,h]P) – would require the use of three laser dyes, namely Rhodamine 640 (DB[a,e]P and
DB[a,h]P), DCM (DB[a,l]P and N[2,3-a]P) and LDS 798 (DB[a,i]P). For the sake of operational
simplicity, we opted to use a single laser dye (DCM) for sample excitation within the 305– 325
nm range.
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Figure 16. Molecular structures of the 23 PAHs isomers with molecular mass of 302 Da previously identified by NIST in the SRM 1597a. (*) denotes isomers
investigated in this study.

53

Figure 17. 77 K excitation and fluorescence spectra of DB[a,l]P in (A) n-octane, (B) n-nonane and (C) n-decane at
100 ng mL-1. The spectra were collected at maximum excitation and emission wavelengths with a 1 nm band pass
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Figure 18. 77 K excitation and fluorescence spectra of DB[a,e]P in (A) n-octane, (B) n-nonane and (C) n-decane at
100 ng mL-1. The spectra were collected at maximum excitation and emission wavelengths with a 1 nm band pass.
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Figure 19. 77 K excitation and fluorescence spectra of DB[a,i]P in (A) n-octane, (B) n-nonane and (C) n-decane at
100 ng mL-1. The spectra were collected at maximum excitation and emission wavelengths with a 1 nm band pass.
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Figure 20. 77 K excitation and fluorescence spectra of DB[a,h]P in (A) n-octane, (B) n-nonane and (C) n-decane at
100 ng mL-1. The spectra were collected at maximum excitation and emission wavelengths with a 1 nm band pass
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Figure 21. 77 K excitation and fluorescence spectra of DB[a,h]P in (A) n-octane, (B) n-nonane and (C) n-decane at
100 ng mL-1. The spectra were collected at maximum excitation and emission wavelengths with a 1 nm band pass.
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Table 5 lists the excitation wavelengths that provided the highest fluorescence intensity for
each HMW-PAHs within the wavelength excitation range of DCM. The delay (td) and gate (tg)
widths were optimized to collect most of the PAH fluorescence and still avoid instrumental noise.
The gate steps (ts) were optimized to record a sufficient numbers of data points within the lifetime
decay of each PAHs. With the exception of DB[a,i]P, the highest fluorescence intensity and
narrowest full-width half-maximum (FWHM) were obtained with the n-alkane that best matched
the length of the PAH. Within a confidence interval of 95% (N1 = N2 = 3),

128

the highest

fluorescence intensity and narrowest FWHM of DB[a,i]P were obtained in n-octane and n-decane.
The choice of n-alkane did not cause considerable changes in the lifetimes of the studied PAHs.
Well-behaved, single exponential decays of fluorescence intensity versus time were observed in
all cases. The first two lifetimes decay agreed to within about 1% and the residuals showed no
systematic trends.
Figure. 22A – E show the 4.2 K LETRSS fluorescence spectra of DB[a,l]P, DB[a,e]P,
DB[a,i]P, N[2,3-a]P and DB[a,h]P in their best matching n-alkane solvent. Table 6 summarizes
the 4.2 K LETRSS AFOMs of each isomer using the current International Union for Pure and
Applied Chemistry (IUPAC) guidelines 129. Calibration curves were built using a minimum of five
standard solutions of each PAHs. All fluorescence measurements were made at the maximum
emission wavelength of each PAHs. No attempts were made to reach the upper concentration limit
of the linear dynamic range (LDR). All intensities plotted in the calibration graphs were measured
under the optimum delay and gate times for each PAHs (see Table 5). The existence of linear
relationships was confirmed by comparing experimental F-test values (Fexp) to critical F-test values
(Fcrit). Fexp were calculated using equation 3.1:
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𝑆𝑦/𝑥

𝐹𝑒𝑥𝑝 = (

𝑆𝑦

2

)

(3.1)

Where Sy/x is the residual standard deviation and Sy is the pure error. These parameters can
be calculated from the calibration data with equations 3.2 and 3.3:
∑𝐼𝑖=1(𝑦𝑖 −ŷ𝑙 )2

𝑆𝑦/𝑥 = √

(3.2)

𝐼−2

𝑄

𝐿

∑𝑙=1 ∑𝑞=1(𝑦𝑙𝑞 −𝑦𝑙 )
𝑆𝑦 = √
𝐼−𝑄

2

(3.3)

where yi and ŷl are the experimental and estimated response values for sample i, ylq is the
calibration response for replicate q at level l, yl is the mean response at level l, and I, L, and Q are
the total number of calibration samples, levels, and replicates at each level, respectively. In all
cases, the Fexp was lower than Fcrit demonstrating the excellent linear relationships between PAH
concentrations and fluorescence signal. The LODs were calculated according to equation 3.4:
𝐿𝑂𝐷 =

3.3𝑆𝑦/𝑥
𝐴

√1 + ℎ0 +

1

(3.4)

𝐼

where A to the slope of the calibration graph, I is the number of calibration samples, and
h0 is the leverage for the blank sample shown equation 3.5:
ℎ0 = ∑𝐼

2
𝐶𝑐𝑎𝑙

(3.5)

2
𝑖=1(𝐶𝑖 −𝐶𝑐𝑎𝑙 )

Where Ccal refers to the mean calibration concentration and Ci is each of the calibration
concentration values.
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The LODs varied from 0.02 µg L-1 (DB[a,l]P and N[2,3-a]P) to 0.24 µg L-1 (DB[a,e]P).
Similar concepts apply to the limit of quantitation (LOQ) as shown in equation 3.6,
𝐿𝑂𝑄 =

10𝑆𝑦/𝑥
𝐴

√1 + ℎ0 +

1

(3.6)

𝐼

Which corresponds to lowest linear concentration in LDR. The RSD values reflect the
excellent reproducibility of LETRSS measurements. All further studies were carried out using the
n-alkane solvents listed in Table 6.
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Figure 22. 4.2 K LETRSS fluorescence spectra of 100 ng mL (A) DB[a,l]P in n-octane (λexe= 318.0 nm, λem = 415.4
nm, 0 ns delay and 250 ns gate time); (B) DB[a,e]P in n-octane (λexe= 306.4 nm, λem = 392.4 nm, 10 ns delay and 150
ns gate time); (C) DB[a,i]P in n-decane (λexc= 312.0 nm, λem = 428.3 nm, 10 ns delay and 650 ns gate time); (D) N[2,3a]P in n-decane (λexe= 317.0 nm, λem = 457.8 nm, 0 ns delay and 25 ns gate time) and (E) DB[a,h]P in n-decane (λexc
= 310.0 nm, λem = 446.6 nm, 0 ns delay and 15 ns gate time). All spectra correspond to the accumulation of 100 laser
pulses. The spectrograph slit was 42µm
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Table 5 Spectral comparison of five HMW-PAH isomers via 4.2 K LETRSS
HMW-PAHs a

n-alkane

λexc/λem b,g (nm)

td/tg/ts c (ns)

IF ( x 105) d (counts)

FWHM e (nm)

τ f,h (ns)

DB[a,l]P

n-octane
n-nonane
n-decane

318.0/415.4
318.0/415.7
318.0/415.6

10/250/6

39.4 ± 0.81
7.28 ± 0.17
6.92 ± 0.11

0.23 ± 0.01
0.69 ± 0.01
0.52 ± 0.01

78.1 ± 1.03
77.5 ± 0.83
77.3 ± 0.86

DB[a,e]P

n-octane
n-nonane
n-decane

306.4/392.2
305.0/391.9
306.0/392.4

10/150/5

1.19 ± 0.07
0.64 ± 0.01
0.72 ± 0.03

0.28 ± 0.01
0.38 ± 0.03
0.61 ± 0.03

54.3 ± 1.39
63.9 ± 2.49
67.0 ± 1.25

DB[a,i]P

n-octane
n-nonane
n-decane

312.0/428.3
312.0/428.8
312.0/428.3

10/650/20

11.6 ± 0.20
8.57 ± 0.10
11.9 ± 0.30

0.32 ± 0.01
0.51 ± 0.01
0.33 ± 0.01

216.2 ± 1.70
226.2 ± 2.40
211.6 ± 7.20

N[2,3-a]P

n-octane
n-nonane
n-decane

318.0/456.9
317.0/455.8
317.0/457.8

0/25/1

16.5 ± 0.70
10.2 ± 0.50
26.4 ± 0.30

0.72 ± 0.05
1.12 ± 0.09
0.29 ± 0.01

7.90 ± 0.11
7.90 ± 0.01
6.83 ± 0.05

DB[a,h]P

n-octane
n-nonane
n-decane

310.0/445.6
310.0/446.5
310.0/446.6

0/15/1

17.1 ± 0.10
31.6 ± 0.60
50.0 ± 0.60

0.44 ± 0.01
0.58 ± 0.02
0.31 ± 0.01

6.17 ± 0.14
6.30 ± 0.10
6.31 ± 0.09

a

All HMW-PAH solutions were made in their perspective n-alkane solvents.

b

Excitation (λexc) and fluorescence (λem) wavelengths.

c

Optimum gate delay (td), gate width (tg) and gate step (ts).

d

Fluorescence intensity (IF) of HMW-PAHs in the frozen n-alkane matrices. All fluorescence intensities represent an average of nine independent measurements made
at the maximum emission wavelengths of each HMW-PAH.
e

Full width at half-maximum (FWHM).

f

Average fluorescence lifetime of three measurements taken from three frozen aliquots.

g, h

See appendices B and C respectively.
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Table 6 AFOM for the five HMW-PAHs via 4.2 K LETRSS in their optimal n-alkane solvents
HMW-PAHa,f

n-alkane

LDRb (µg L-1)

R2 c

LODd (µg L-1)

RSDe (%)

DB[a,l]P

n-octane

0.05 – 100

0.9981

0.02

3.96

DB[a,e]P

n-octane

0.94 – 100

0.9996

0.29

5.88

DB[a,i]P

n-decane

0.19 – 100

0.9974

0.06

2.19

N[2,3-a]P

n-decane

0.17 – 50

0.9975

0.05

2.15

DB[a,h]P

n-decane

0.12 – 50

0.9998

0.04

2.67

a

All HMW-PAH solutions were made in their perspective n-alkane solvents.
c
LDR, linear dynamic range; lower concentration limit =LOQs were calculated on the basis of equation 3.6.
d
R = correlation coefficient.
e
LODs were calculated on the basis of equation 3.4.
e
Relative standard deviation (RSD) = SF/IF x 100, where SF is the standard deviation of the average calculated from six
fluorescence measurements at medium linear PAH concentrations.
f
see appendix D for calibration curves.
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3.3.3. Pre-concentration of HPLC Fractions for 4.2 K LETRSS Analysis
Several approaches have been reported for the pre-concentration of PAHs from HPLC
fractions. These include liquid-liquid extraction (LLE)
117,127,130

, evaporation (EVAP)

94,128

and SPNE

118

117,127,130

, solid-phase extraction (SPE)

. This section compares the analytical

performance of EVAP and SPNE for the LETRSS analysis of the five targeted isomers. Both
methods have the strengths of simplicity, cost effectiveness and reduced solvent consumption. Preconcentration via EVAP is accomplished by applying a steady stream of ultrapure nitrogen gas for
approximately 30 min and re-dissolving the solid residue with microliters of Shpol’skii solvent for
LETRSS analysis. SPNE pre-concentrates PAHs by mixing the HPLC fraction with Au NPs. After
centrifugation and decantation of the supernatant, the Au NPs precipitate is mixed with a PAH
releasing solvent mixture (1-pentanethiol/methanol/n-alkane) for LETRSS analysis.
Table 7 summarizes the AFOMs of HPLC-EVAP-LETRSS and HPLC-SPNE-LETRSS
analysis for the five HMW-PAHs. Overall recovery (OR) values were calculated according to
equation 3.7:
𝑂𝑅 (%) =

[𝑃𝐴𝐻]𝐴 ∗𝑉𝐴
𝐶𝑃𝐴𝐻 ∗ 𝑉𝑆

∗ 100

(3.7)

where CPAH refers to the PAH concentration in the original sample, VS to the extracted
volume of sample, [PAH]A corresponds to the concentration of PAH in the final volume of nalkane solvent (VA). As shown in Figure 23, the optimum VA values for EVAP were 400 µL.
Previous work in our lab has shown that 50 µL of n-alkane solvent is sufficient to achieve excellent
analytical recoveries of PAHs118-123.
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Figure 23. The overall recoveries for the evaporation step of the HPLC fractions when adding different amounts of
the appropriate n-alkane solvent (see Table 6). VA values were obtained from three chromatographic runs of a five
PAH synthetic mixture containing 10 ng mL-1 individual isomer concentrations
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Table 7 AFOM comparison for the pre-concentration of the 5 HMW-PAHs in HPLC fractions

EVAP-LETRSSg
HMW-PAH a

OR b
(%)

LDR c
(µg L-1)

R

DB[a,l]P
DB[a,e]P
DB[a,i]P
N[2,3-a]P
DB[a,h]P

100. ± 3.42
97.2 ± 4.37
97.5 ± 1.93
98.6 ± 2.63
98.4 ± 2.84

0.94 – 100
18.0 – 100
3.68 – 100
3.36 – 100
2.61 – 100

0.9981
0.9996
0.9974
0.9975
0.9998

2d

SPNE-LETRSSh
LOD e
(µg L-1)

RSD f
(%)

OR b
(%)

LDR c
(µg L-1)

R

0.29
5.45
1.12
1.02
0.79

3.41
4.49
1.98
2.67
2.89

98.2 ± 5.5
99.5 ± 2.8
102.7 ± 3.2
102.6 ± 4.1
102.2 ± 6.0

0.12 – 10
2.30 – 10
0.47 – 10
0.43 – 10
0.27 – 10

0.9990
0.9940
0.9994
0.9955
0.9992

a

2d

LOD e
(µg L-1)

RSD f
(%)

0.04
0.70
0.14
0.13
0.09

5.60
2.81
3.12
4.00
5.87

All HMW-PAH synthetic mixture solutions were made in methanol.
OR, overall recovery of HMW-PAHs.
c
LDR, linear dynamic range; lower concentration limit =LOQs were calculated on the basis of equation 3.6.
d
R = correlation coefficient.
e
LODs were calculated on the basis of equation 3.4.
f
Relative standard deviation (RSD) = SF/IF x 100, where SF is the standard deviation of the average calculated from six fluorescence
measurements at medium linear PAH concentrations.
g, f
see appendices E and F respectively for calibration curves.
b
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Within a confidence interval of 95% and three replicate trials (α = 0.05; N = 3), the obtained
overall recoveries in Table 7 for both pre-concentration methods were statistically equivalent to
100% 128. Each calibration curve was built with at least five synthetic mixtures of HMW-PAHs.
Each signal plotted in the calibration graph was the average of at least three HPLC-LETRSS
measurements recorded from three independent aliquots. AFOM were calculated based on the
same equations described in section 3.2.2. No efforts were made to reach the upper linear
concentration of the LDR. SPNE provided better LODs than EVAP. The LOD improvements
result from the 8x smaller n-alkane volume (VA) of the procedures of SPNE (50 µL) in comparison
to the EVAP (400 µL). All further studies were then carried out using SPNE as the preconcentrating approach for HPLC-LETRSS analysis.
3.3.4. Accuracy of HPLC-SPNE-LETRSS
Table 8 compares the NIST mass fraction certified values of the five targeted HMW-PAHs to
those obtained in our lab via HPLC-SPNE-LETRSS. The NIST certified values correspond to the
averages of the mass fractions obtained with methods I-V (see Figure 14). Within a confidence
interval of 95% and three replicate trials (N = 3), the mass fractions obtained via HPLC-SPNELETRSS were statistically equivalent to the NIST certified values. It should be noted that only one
of the NIST methods (Method III) was able to determine all five isomers in the coal tar sample
extract.
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Table 8 Comparison of certified and the experimental concentrations for 5-HMW PAHs
HMW-PAH

Reported Values a
(mg Kg-1)

Experimental b
(mg Kg-1)

t-test c

DB[a,l]P

1.12 ± 0.08

0.93 ± 0.16

1.50

DB[a,e]P

9.08 ± 0.20

9.47 ± 0.51

1.43

DB[a,i]P

3.87 ± 0.17

3.64 ± 0.36

1.14

N[2,3-a]P

4.29 ± 0.45

3.67 ± 0.79

1.45

DB[a,h]P

2.57 ± 0.15

2.50 ± 0.27

0.48

a

Mass fraction and standard deviations from the certificate of analysis for SRM 1597a.
Mass fraction and standard deviations determine from the HPLC fractions via 4.2 K SPNELETRSS.
c
t-test of PAH concentrations from HPLC fractions compared to concentration values listed in
the certificate of analysis. tcritical = 2.78 (α = 0.05; Nrep = 2 – 5 and Nexp = 3)
b

Figure 24A – E shows the 4.2 K fluorescence spectra and lifetimes of the five targeted isomers
obtained from the HPLC fractions of the coal tar sample. Each spectrum was recorded using the
best gate and excitation wavelengths listed in Table 1.
Table 9 compares the 4.2 K fluorescence lifetimes of pure standards to those recorded from
HPLC fractions of the SRM 1597a sample. The statistical equivalence observed in all cases (α =
0.05; N1 = N2 = 6)

128

confirms peak assignments for the unambiguous determination of each

molecular mass 302 isomer. Single exponential decays were observed in all cases demonstrating
peak purity of HPLC fractions for accurate quantitative analysis of HMW-PAHs.
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Figure 24. 4.2 K LETRSS fluorescence spectra of the HPLC fractions obtained from the SRM 1597a. In each
spectrum, the target HMW-PAH isomer and experimental parameters were the following: (A) DB[a,l]P in n-octane
(λexc = 318.0 nm, λem = 415.4 nm, 0 ns delay and 250 ns gate time); (B) DB[a,e]P in n-octane (λexc = 306.4 nm, λem =
392.4 nm, 10 ns delay and 150 ns gate time); (C) DB[a,i]P in n-decane (λexc = 312.0 nm, λem = 428.3 nm, 10 ns
delay and 650 ns gate time); (D) N[2,3-a]P in n-decane (λexc = 317.0 nm, λem = 457.8 nm, 0 ns delay and 25 ns gate
time) and (E) DB[a,h]P in n-decane (λexc = 310.0 nm, λem = 446.6 nm, 0 ns delay and 15 ns gate time). All spectra
correspond to the accumulation of 100 laser pulses. The spectrograph slit was 42 μm.
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Table 9. Lifetime analysisa of 5 HMW-PAH isomers
HMW-PAH

Standard b

SRM 1597a c,e

t-test d

DB[a,l]P

78.1 ± 1.03

80.4 ± 2.73

0.37

DB[a,e]P

54.3 ± 1.39

51.4 ± 0.64

2.34

DB[a,i]P

212. ± 7.20

200. ± 5.17

2.29

N[2,3-a]P

6.83 ± 0.05

7.13 ± 0.23

2.23

DB[a,h]P

6.31 ± 0.09

6.14 ± 0.10

0.81

a

The fluorescence lifetime corresponds to the average of three individual measurements
taken from three frozen aliquots at the maximum fluorescence wavelength.
b
Lifetime recorded from a PAH standard solution prepared in the optimum n-alkane solvent.
c
Lifetime recorded from the PAH in the HPLC fraction of the coal tar sample extracted with
the optimum n-alkane solvent.
d
t-test of PAH lifetimes from HPLC fraction compared to standard values. tcritical = 2.78 (α =
0.05; N = 6)
e
see appendix G for PAHs fluorescence decays.
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3.4. Conclusion
Chemical analysis of PAHs with MM 302 is of great environmental and toxicological
importance. Many of them are highly suspect as etiological agents in human cancer. Because their
carcinogenic properties differ significantly from isomer to isomer, it is of paramount importance
to determine the most toxic isomers even if they are present at much lower concentrations than
their less toxic isomers. The main problems that confront HPLC and GC/MS arise from the large
number of HMW-PAH isomers with very similar elution times and similar, possibly even virtually
identical, mass fragmentation patterns. The approach presented here is based on HPLC-SPNELETRSS analysis. The spectral and lifetime information obtained with LETRSS provide the
required selectivity for the unambiguous determination of PAH isomers in the HPLC fractions.
Prior to LETRSS analysis, HPLC fractions are pre-concentrated via SPNE, an environmentally
friendly extraction procedure based on the adsorption of PAHs on the surface of Au NPs

118-127

.

Complete SPNE-LETRSS analysis is possible with microliters of HPLC fractions and organic
solvent. The excellent analytical figures of merit associated to its non-destructive nature, which
provides ample opportunity for further analysis with other instrumental methods makes this
approach an attractive alternative for the analysis of isomers of HMW-PAHs in complex
environmental samples.
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CHAPTER 4. ROOM TEMPERATURE FLUORESCENCE
SPECTROSCOPY OF BENZO[a]PYRENE METABOLITES ON
OCTADECYL EXTRACTION MEMBRANES

4.1. Introduction
Considerable efforts have been made to improve luminescence measurements of
compounds adsorbed on solid substrates 131, 132. As a result, solid surface luminescence analysis is
a widely accepted tool in environmental, pharmaceutical, food and agricultural science

133

.

Particularly attractive is the use of SPE membranes for the on-site analysis of polycyclic aromatic
compounds in water samples 134-138. Attractive features include a simple experimental procedure
and compatibility with portable instrumentation. Due to the non-destructive nature of
luminescence measurements, extraction membranes can be brought to the lab for subsequent
sample elution and fluorophore confirmation via high-resolution techniques 139-142.
Solid surface room temperature fluorescence (RTF) spectroscopy on solid phase extraction
(SPE) membranes was first proposed for the analysis of polycyclic aromatic hydrocarbons (PAHs)
in water samples 135, 143. Octadecyl silica membranes were cut into tabs and subsequently immersed
into aqueous solution for PAHs extraction. Depending on the PAH, the extraction step varied from
one to two hours of immersion time. After drying for 5 min, the tabs were examined via front
surface room-temperature fluorescence spectroscopy to reach LODs at the parts-per-billion (ng
mL−1) level

135, 143

. Later reports from Campiglia and co-workers extended the use of SPE

membranes to the room temperature phosphorimetry (RTP) analysis of PAHs
polychlorinated biphenyls 145, 147 and polychlorinated dibenzofurans148.
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136, 144-146

,

Bulky glassware and vacuum pumps, common to classic SPE lab procedures, were
replaced with a syringe kit well-suited for manual extraction under field conditions. A rapid airdrying step, which was accomplished by applying positive pressure to the syringe, removed the
excess of water from the extraction membrane prior to spectroscopic measurements. Total analysis
-1
time took less than 10min per sample and provided LODs at the parts-per-billion (pg.mL )
concentration level.The same extraction procedure was later applied to the water analysis of PAHs
via SPE-RTF 147.
This chapter focuses on the urine analysis of PAH metabolites via SPE-RTF. Although
chromatographic techniques provide reliable results for the analysis of PAH metabolites 163-171, the
development of easy-to-use and cost effective techniques with high sample throughput is relevant
to assess PAHs uptake by large populations

167

. Previous articles on the urine analysis of PAH

metabolites targeted monohydroxy-PAHs (OH-PAHs) 161,162. Signal reproducibility was improved
with the aid of a sample holder specifically designed for the manual optimization of luminescence
signals. Background correction of solid substrates was carried out with the aid of Asymmetric
Least Squares (ALS), a smoothing algorithm originally devised for baseline correction of
chromatographic data
151,152

.

150

and often applied to matrix interference in chromatographic analysis

2-hydroxy-fluorene

(2OH-FLU),

1-hydroxypyrene

(1OH-PYR),

3-hydroxy-

benzo[a]pyrene (3OH-B[a]P) and 9-hydroxy-phenanthrene (9OH-PHE) were determined in
synthetic urine samples at the parts-per-trillion concentration level

161

. Recovery values varied

from 99.0 ± 1.2% (3OH-B[a]P) to 99.9 ± 0.05% (1OH-PYR). The sample holder improved the
precision of measurements with relative standard deviations (RSD) varying from 3.5% (2OHFLU) to 9.5% (9OH-PHE). The application of ALS to SPE-RTF improved the LODs by
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approximately two orders of magnitude. With only 10 mL of urine sample, the LODs of OH-PAHs
varied from 57 pg mL−1 (2OH-FLU) to 2 pg mL−1(1OH-PYR).
Herein, the application of SPE-RTF is extended to the urine analysis of benzo[a]pyrenetrans-9,10-dihydrodiol (B[a]P-diol), benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol (B[a]P-triol) and
benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol

(B[a]P-tetrol).

RTF

measurements

from

extraction membranes are carried out with the aid of fiber optic probe that eliminates the need for
manual optimization of signal intensities. RSDs varying from 2.07% (B[a]P-triol) to 8.55% (3-OH
B[a]P) were obtained with a straightforward procedure. ALS background correction provided
LODs at the pg.mL-1 range. Analytical recoveries from human urine samples varied from 87.54 ±
3.11% (3OH-B[a]P) to 99.77 ± 2.48% (B[a]P-tetrol). The excellent analytical figures of merit and
the simplicity of the experimental procedure demonstrate the potential of SPE-RTF for screening
biomarkers of PAH exposure in numerous urine samples.
4.2. Experimental
4.2.1. Chemicals and Materials
All solvents were Aldrich HPLC grade. All chemicals were analytical-reagent grade and
utilized without further purification. Unless otherwise noted, Nanopure water was used
throughout. B[a]P-diol, B[a]P-triol and B[a]P-tetrol were purchased from Sigma–Aldrich. 3OHB[a]P was from Midwest Research Institute. All other chemicals were purchased from Fisher
Chemical. The Sep-Pak C-18 membranes were purchased from Varian/Agilent. The synthetic
urine solution was manufactured by RICCA Chemical Company (Arlington, TX) and purchased
from Fischer Scientific. Its chemical composition mimicked main components of human urine at
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the concentrations found in healthy urine samples. Human urine samples obtained from an
anonymous volunteer group of healthy non-smoking individuals were pooled, frozen and stored at
4 °C until further analysis.

4.2.2. Preparation of stock solution of B[a]P metabolites
Stock solutions of B[a]P metabolites (100 µg/mL) were prepared by dissolving 1.0 mg of
o

standard in 10 mL of methanol. All stock solutions were kept in the dark at 4 C. Prior to use,
stock solutions were monitored via RTF spectroscopy for possible photo-degradation of
metabolites. Spectral profiles and fluorescence intensities of stock solutions remained the same for
a period of six months. Working solutions of B[a]P metabolites were prepared daily by serial
dilution of stock solutions.
4.2.3. Hydrolysis of urine samples
Urine samples (8 mL) were spiked with 1 mL of metabolite stock solution of appropriate
concentration and equilibrated for 30 min to allow for the interaction of B[a]P metabolites with
urine components such as urea and various salts. Then 500 µL of 0.1 M HCl was added to the
sample and the mixture was buffered with 500 µL of 0.05 M potassium biphthalate sodium
hydroxide buffer (pH 5.0). The buffered sample was shaken for 30 min at 1400 rpm to allow for
urine hydrolysis. 161, 162
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4.2.4. SPE with octadecyl membranes
A cork borer with an inside diameter of 8 mm was used to dissect a 47 mm C18 membrane
into 8 mm extraction disks. An 8 mm disk was loaded into a stainless steel filter syringe kit
(Alltech) and connected to a 10 mL Hamilton syringe (see Figure 13B). Positive pressure was used
to force all liquid solutions through the disk. Prior to sample application, the extraction membrane
was conditioned with 5 mL of methanol and 5 mL of water.
Optimization of experimental parameters concerning the retention of B[a]P metabolites on
extraction membranes led to the following procedure: aqueous metabolite solutions or synthetic
urine samples were processed through extraction membranes previously conditioned with 5 mL
methanol and 5 mL water. Following sample extraction, each membrane was sequentially rinsed
with 5 mL of water and 5 mL of 1% ammonium hydroxide. Void water was mechanically removed
from the membrane with a 100 mL syringe forcing three 100 mL volumes of air through the disk.
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4.2.5. RTF measurements
The FOP used for these studies was described in the previous chapters of this dissertation.
Fluorescence measurements were carried out with a FluoroMax-3 (Horiba Jobin Yvon, Edison,
NJ) equipped with a 450 W xenon arc source. The 1200 grooves/mm gratings in the single
excitation and emission monochromators were blazed at 330 and 500 nm, respectively. Their
reciprocal linear dispersion was equal to 4.25 nm/ mm. The uncooled photomultiplier tube
(Hamamatsu, Model R928) detector was operated in the photon- counting mode. Commercial
software (DataMax, version 2.20, Horiba Jobin Yvon) was used for automated scanning and
fluorescence data acquisition. The excitation fiber and the emission bundle of the FOP were
coupled to the sample compartment of the spectrofluorimeter with the aid of a commercial fiber
optic mount (F-3000, Horiba Jobin Yvon) that optimized collection efficiency via two concave
mirrors (see Figure 25). Position alignment of each end of the FOP with the respective focusing
mirror was facilitated using commercially available adapters (Horiba Jobin Yvon).
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Figure 25 Schematic diagrams of the fiber optic probe and the fiber optic mount used for room-temperature
fluorescence measurements.
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4.2.6. ALS Software
Routines for data pre-treatment and processing were written in MATLAB 153. Baseline
routines for emission background correction were adapted from routines previously described in
the literature for baseline correction of chromatographic data 154. Implementation of the ALS
algorithm included a smoothing parameter equal to 1 × 107, an asymmetry parameter equal to
0.001, an order of differences in penalty equal to 3 and a single regularization parameter, whose
value was 1.
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4.3. Results and Discussion
During the past decades, considerable efforts have been made to develop bio-analytical
assays for the determination of PAH metabolites in physiological fluids. Depending on the
complexity of the sample and the relative concentrations of the targeted metabolites, a combination
of preparation techniques is often necessary to reach the limits of detection of the instrumental
method of analysis.56-59 Analysis of metabolites has been accomplished via HPLC, capillary
electrophoresis (CE) and GC. Ultraviolet –visible absorption and room temperature fluorescence
detection have been widely used with both HPLC and CE 60-65. The ultimate specificity belongs to
high-resolution MS either coupled to gas chromatography (GC-MS) or HPLC (HPLC-MS).52-54,
66-68

.
The molecular structures of the metabolites chosen for this study are shown in Figure 26.

These four compounds provide an example of the rich and heterogeneous distribution of metabolic
products B[a]P produce. B[a]P is the most toxic PAH in the EPA priority pollutants list and it is
often used as a measure of risk. A summary of the analytical approaches developed for their
determination in urine samples is presented in Table 10. Our literature search revealed no reports
on the analysis of B[a]P-triol in urine samples. Examination of Table 10 shows a wide range of
SPE recoveries for the studied metabolites. SPE procedures often elute B[a]P metabolites with
milliliter volumes of methanol, which are then evaporated to micro-litters (or even dryness) for
sample pre-concentration. These steps are prone to metabolite loss and poor analytical recoveries.
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Table 10 Analytical figures of merit reported for B[a]P metabolites analysis in urine samples by different analytical methods
Metabolites
3-OH B[a]P
3-OH B[a]P
3-OH B[a]P
3-OH B[a]P
B[a]P-diol
B[a]P-diol

LOD
(ng L-1)

Recovery
%

Sample preparation

Instrumental method

Analysis time
(min)a

Reference

1615
40
44

40
48
68
80
79
90

SPE, evaporation
SPE, evaporation
SPE, evaporation
SPE, evaporation
SPE, evaporation
SPE, evaporation

40
45
41
7
70

169
170
171
166
167b
172

45

168b

34

LLEa, evaporation, HPLC fraction
,derivatization
SPE, evaporation, HPLC fraction

HPLC
HPLC
HPLC
LC-MS/MS
HPLC
Spectrofluorometric
detection
GC-MS

B[a]P-diol

70

B[a]P-tetrol

10

B[a]P-tetrol
B[a]P-tetrol
B[a]P-tetrol

50

SPE, evaporation
SPE, evaporation
SPE, evaporation, HPLC fraction,
derivatization
a
instrumental analysis only; does not include sample preparation procedures
b
in rat urine
b
LCC= liquid –liquid extraction
44

82

Fluorescence
spectroscopy
HPLC
GC-MS/MS
GC-MS/MS

173
14
14
15

163
164
165

Figure 26. Molecular structures of (A) 3-hydroxy-benzo[a]pyrene (B) benzo[a]pyrene-trans-9,10-dihydrodiol (C)
benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol and (D) benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol
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4.3.1. RTF analytical figures of merit (AFOM) of B[a]P metabolites in aqueous solutions
Figure 27 shows the initial survey of room-temperature excitation and fluorescence spectra
of B[a]P metabolites in methanol/water (10% v/v) solutions. All measurements were made from
standard (1 × 1 cm) quartz cuvettes filled with undegassed solutions. All spectra were collected at
90◦ from the excitation beam using 3 nm excitation and emission band-pass. No attempts were
made to adjust slit widths for optimum spectral resolution, nor were the spectra corrected for
instrumental response. The 3 nm band-pass provided signal-to-blank ratios higher than 3 for all
the studied metabolites at the trace concentration level. No significant changes were observed from
spectra of B[a]P metabolites in hydrolyzed urine samples or adsorbed on extraction membranes.
Table 11 summarizes the RTF AFOM of the studied metabolites. All measurements were
made at the maximum excitation and fluorescence wavelengths of each compound. Each
calibration curve was built with a minimum of four B[a]P metabolites concentrations. For each
concentration plotted in the calibration graph, the RTF intensity was the average of three
determinations taken from three sample aliquots (N = 3). No efforts were made to experimentally
obtain the upper concentration limit of the calibration curve. The correlation coefficients of the
calibration curves were close to unity, indicating a linear relationship between metabolite
concentration and signal intensity. The linearity was also evaluated by an ANOVA test as
suggested by IUPAC

160

with satisfactory results. The LOD were calculated using the equation

LOD = 3 ×SB/m, were SB is the standard deviation of 16 blank determinations and m is the slope
of the calibration curve. The limits of quantitation (LOQ) were calculated with the formula LOQ
= 10 × SB/m. The slopes of the calibration curves were obtained with the least squares method.
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The strong fluorescence intensity resulting from the rigid and delocalized π -electron
system of B[a]P metabolites provides LOD and LOQ values at the ng mL
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−1

concentration level.

-1

Figure 27. Room-temperature excitation and fluorescence spectra of (A) 20ng.mL 3-hydroxy-benzo[a]pyrene, (B)
-1

-1

20ng.mL benzo[a]pyrene-trans-9,10-dihydrodiol, (C) 20ng.mL benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol and (D)
-1

20ng.mL benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol recorded from pure standard solutions prepared in 10%
methanol/water
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Table 11 RTF Analytical figures of Merit in 10% methanol/water solutions
B[a]P metabolite

exc/ema (nm)

LDRb
(ng mL-1)

R2c

RSDd

LODe
(ng mL-1)

3-OH B[a]P



3.73-40

0.9902

4.5

1.22

B[a]P-diol



2.40-40

0.9918

1.02

0.72

B[a]P-triol



1.06-40

0.9975

1.69

0.32

B[a]P-tetrol



0.97-40

0.9979

2.02

0.29

a

Excitation and emission wavelengths.

b

LDR = linear dynamic range extending from the limit of quantification (LOQ) to an arbitrarily

chosen upper linear concentration. LOQ defined as 3.3 × LOD.
c
d

Correlation coefficient of calibration curve.
RSD = relative standard deviation in %. Calculated as RSD = [S av/Xav]*100; where Sav is the

standard deviation and Xav is the average intensity of three independent measurements from three
aliquots.
e

Limit of detection in calculated as 3×SB/m, where SB is the standard deviation of 16 blank

measurements and m is the slope of the calibration curve.
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4.3.2. Extraction efficiency of SPE membranes
The percentages of extraction (%E) were calculated with the formula %E = (IBE – IAE /
IBE) x100, where IBE and IAE refer to the fluorescence signals before and after extraction,
respectively. In all cases, the volume of extracted sample was 10mL. The mass of extracted
metabolite did not surpass the nominal breakthrough mass (30mg) of extraction membranes. Table
12 compares %E values obtained from standard solutions to those from hydrolyzed urine samples.
All values are the averages of three aliquots submitted to the entire extraction procedure. Within a
confidence interval of 95% (N=3), all %E are equivalent to 100%. This fact excludes the possibility
of matrix interference on the retention of B[a]P metabolites. Similar results were obtained with
other B[a]P metabolites concentrations within the LDR of Table 11. Keeping in mind that
metabolite elution is not required for the determination of B[a]P metabolites via SPE-RTF, the %E
values in Table 12 correspond to the analytical recovery of the method. As shown in Table 13 the
%E values obtained from standard solutions are statistically the same as those obtained from urine
samples. This is an indication that the chemical compositions of synthetic and human urine
samples do not interfere with the retention of B[a]P metabolites on extraction membranes.
.
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Table 12 Percentage of metabolite retention on C-18 membranes from aqueous solutions, synthetic
urine and human urine samples
B[a]P metabolite

From Aqueous solution

synthetic urine

Human urine

3-OH B[a]P

± 3.11

90.31 ± 2.79

82.11 ± 4.91

B[a]P-diol

± 3.14

97.76 ± 2.78

93.93 ± 3.53

B[a]P-triol

± 4.32

98.10 ± 2.17

92.43 ± 3.76

B[a]P-tetrol

±

98.87 ±

91.89 ± 4.10

Table 13 Statistical comparison of %E values in Table 12
B[a]P metabolite

t (expt) H2O/synthetic

t(expt) H2O/human

t(expt) synthetic/human

3-OH B[a]P

0.469193

0.16714

0.927503

B[a]P-diol

0.233704

0.285553

0.582858

B[a]P-triol

0.071291

0.228799

0.836501

B[a]P-tetrol

0.155645

0.338096

0.922704

* t critical =2.78; P = 95%, N1 = 3; N2 = 3.
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4.3.3 AFOM of B[a]p metabolites via SPE-RTF
The SPE-RTF AFOMs of the four studied metabolites are summarized in Table 14. SPE was
carried out with 10mL of standards prepared in 10% methanol/water (v/v). For each concentration
plotted in the calibration graph, the RTF intensity was the average of at least three determinations
taken from three extraction disks (N = 9). The LDR were obtained with a minimum of five B[a]P
metabolites concentrations. No efforts were made to experimentally obtain the upper concentration
limits of the calibration curves. It is important to note, however, that the highest concentration
plotted in each calibration curve did not surpass the breakdown volume of the SPE device 146. The
correlation coefficients of the calibration curves and the slopes of the log-log plots (data not
shown) were close to unity, indicating a linear relationship between B[a]P metabolite
concentration and fluorescence intensity. Satisfactory results were also obtained by the ANOVA
160

test suggested by IUPAC

. The RSD at medium linear concentrations were lower than 10%. The

LOD were estimated at the parts-per-billion to sub-parts-per-billion concentration levels. Their
comparison to the LOD values in Table 11 shows no advantage of pre-concentrating the sample
prior to RTF. Table 15 compares the slopes of the calibration curves, blank intensities and their
standard deviations from aqueous solutions to those obtained on extraction membranes. The
calibration graphs are shown in Figure 28 and Figure 29. Sample pre- concentration via SPE
provides 10-fold improvements on the slopes of the calibration curves. The main reason for the
lack of LOD improvements is the higher intensities of blank signals and their respective standard
deviations on extraction membranes. Better SPE-RTF LOD could have been obtained by
extracting 100mL volumes of standard solutions, i.e. an alternative with little appealing in the
screening context of human urine samples.
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Table 14 SPE-RTF AFOM of B[a]P metabolites
λexc/λema

LDRb

3-OH-B[a]P

R2 c

LOD d

381/425

(ng mL-1)
9.91-40

0.9746

(ng mL-1)
2.97

B[a]P-diol

345/405

2.78-40

0.9935

0.84

B[a]P-triol

345/380

4.23-40

0.9981

1.27

B[a]P-tetrol

345/375

2.91-40

0.9967

0.87

B[a]P metabolite

a

Excitation and emission wavelengths.

b

LDR = linear dynamic range extending from the limit of quantification (LOQ) to an arbitrarily

chosen upper linear concentration. LOQ defined as 3.3 x LOD.
c

Correlation coefficient of calibration curve.

d

Limit of detection calculated as 3xSB / m; where SB is the standard deviation of 6 blank

measurements and m is the slope of the calibration curve.
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Table 15 Slope and blank signals obtained from calibration curves in Table 14
Slope a

B[a]P

Average blank intensity ± standard deviation b

metabolites

(cps)
H2O (x103)

Membrane

H2O ( x103)

Membrane (x 104)

(x104)
3-OH B[a]P

3.88

2.33

8.50 ± 0.63

6.15 ± 0.48

B[a]P-diol

2.04

8.50

1.32 ± 0.23

5.52 ± 0.25

B[a]P-triol

2.60

8.10

2.15 ± 0.28

7.35 ± 0.18

B[a]P-tetrol

2.83

8.21

2.27 ± 0.29

7.34 ± 0.21

a

Slope of linear dynamic range obtained via the least squares method.

b

Average values based on three individual measurements recorded from the extraction membrane

submitted to the entire procedure.
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Figure 28. Calibration curve of (A) 3-hydroxy-benzo[a]pyrene, (B) benzo[a]pyrene-trans-9,10-dihydrodiol, (C)
benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol and (D) benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol recorded from
pure standard solutions prepared in 10% methanol/water (v/v).
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Figure 29. Calibration curve of (A) 3-hydroxy-benzo[a]pyrene, (B) benzo[a]pyrene-trans-9,10-dihydrodiol, (C)
benzo[a]pyrene-r-7,t-8,c-9-tetrahydrotriol and (D) benzo[a]pyrene-r-7,t-8,c-9,c-10-tetrahydrotetrol recorded from
extraction membranes.
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4.3.4. Background correction via ALS
The ALS algorithm uses the Whittaker smoother for discrete (time) series, which
150

minimizes the function

:
𝑄 = ∑ 𝑣𝑖 (𝑦𝑖 − 𝑓𝑖)2 + 𝑝
𝑖

Where y is the data (experimental signal), f a smooth trend (or baseline estimation),  prior weights,
and p the asymmetry parameter. The successful implementation of ALS to the background
7
correction of extraction membranes was achieved with a smoothing parameter equal to 1 x 10 ,
an asymmetry parameter equal to 0.001, an order of differences in penalty equal to 3 and a single
regularization parameter. Figure 30 clearly shows the improvement that was obtained with the
implementation of ALS. The background intensity (IB) of extraction membranes was considerably
reduced and so it was the standard deviation (SB) of the average background signals. Table 16
summarizes the effect of ALS on the SPE-RTF AFOM of the studied metabolites. Comparison to
Table 14 reveals LOD improvements ranging from 25x (B[a]P-triol) to 42x (B[a]P-diol). The LOD
in Table 16 meet the expectations for the analysis of B[a]P metabolites in urine samples.
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Table 16 SPE-RTF-ALS AFOM of B[a]P metabolites
PAH metabolite

λexc/λema

3-OH- B[a]P
B[a]P-diol
B[a]P-triol
B[a]P-tetrol

381/425
345/405
345/380
345/375

LDRb
( ng mL-1)
0.37-40
0.10-40
0.16-40
0.11-40

R2 c
0.9924
0.9995
0.9987
0.9966

LOD d
( ng mL-1)
0.11
0.02
0.05
0.03

a

Excitation and emission wavelengths.
LDR = linear dynamic range extending from the limit of quantification (LOQ) to an arbitrarily chosen
upper linear concentration. LOQ defined as 3.3 x LOD.
c
Correlation coefficient of calibration curve.
d
Limit of detection calculated as 3xSB / m; where SB is the standard deviation of 6 blank
measurements and m is the slope of the calibration curve.
b

A
B
A
Figure 30. Blank signals (A) before and (B) after blank ALS background correction.
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4.4. Conclusion
Several features make SPE-RTF spectroscopy a well-suited approach for screening B[a]P
metabolites in urine samples. Its straightforward experimental procedure is attractive for routine
analysis of numerous samples. The direct determination of B[a]P metabolites on the surface of the
extraction membrane eliminates the need for subsequent elution steps and provides excellent (~
100%) metabolite recoveries. Acceptable precision for analytical work is possible with the aid of
FOP specifically designed for manual optimization of maximum fluorescence signals. Background
correction of extraction membranes via ALS provides LOD at the parts-per- trillion concentration
level. With 10mL of urine samples, the LOD varied from 20 pg.mL-1 (B[a]P-tetrol) to 110 pg.mL1 (3-OH-Pyr). These values compare favorably to LOD previously reported via chromatographic
methods 155-159.

97

CHAPTER 5. FUTURE WORK
That we can measure and analyse DB[a,l]P, DB[a,i]P, DB[a,e]P, N[2,3-a]P and DB[a,h]P
in HPLC fractions of complex environmental extracts is no longer in question. But our ability to
do the same with the other 18 commercially available isomers of MW 302 has not been
demonstrated yet. Research in our lab will answer this question by removing the limitations that
have plagued the analysis of HMW-PAHs for the past decades.
The proposed methodology is not restricted to a single MW and can be extended to
significantly large structures in the future. The number of structural isomers increases rapidly with
the number of condensed rings. This fact makes chromatographic analysis of organic pollutants
with MW higher than 302 even more challenging. Future developments in this direction should
have implications in environmental site characterization and remediation, health research, and
fundamental laboratory studies.
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APPENDIX A: RT FLUORESCENCE EXCITATION-EMISSION
SPECTRA OF HMW-PAHS
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Figure A-1. Room temperature excitation-emission fluorescence spectra of 50 ng mL-1 DB[a,l]P standard were recorded in 100% acetonitrile. Excitation and
emission bandpass was 3nm.
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Figure A-2. Room temperature excitation-emission fluorescence spectra of 50 ng mL-1 DB[a,e]P standard were recorded in 100% acetonitrile. Excitation and
emission bandpass was 3nm.
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Figure A-3. Room temperature excitation-emission fluorescence spectra of 50 ng mL-1 DB[a,i]P standard were recorded in 100% acetonitrile. Excitation and
emission bandpass was 3nm.
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Figure A-4. Room temperature excitation-emission fluorescence spectra of 50 ng mL-1 N[2,3-a]P standard were recorded in 100% acetonitrile. Excitation and
emission bandpass was 3nm.
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Figure A-5. Room temperature excitation-emission fluorescence spectra of 50 ng mL-1 DB[a,h]P standard were recorded in 100% acetonitrile. Excitation and emission
bandpass was 3nm.
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APPENDIX B: FLUORESCENCE EMISSION SPECTRA OF HMW-PAHS
AT 4.2K
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Figure B-1 4.2 K LETRSS fluorescence spectra of 100 ng mL DB[a,l]P standard were recorded in (A) n-octane; λex = 318.0
nm, (B) n-nonane; λex = 318.0 and (C) n-decane; λex = 318.0 nm using a 0 ns delay and 250 ns gate time. All spectra correspond
to the accumulation of 100 laser pulses. The spectrograph slit was 42 μm.
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Figure B-2. 4.2 K LETRSS fluorescence spectra of 100 ng mL-1 DB[a,e]P standard were recorded in (A) n-octane; λex = 306.4 nm, (B) nnonane; λex = 305.0 and (C) n-decane; λex = 306.0 nm using a 10 ns delay and 150 ns gate time. All spectra correspond to the accumulation
of 100 laser pulses. The spectrograph slit was 42 μm.
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Figure B-3. 4.2 K LETRSS fluorescence spectra of 100 ng mL-1 DB[a,i]P standard were recorded in (A) n-octane; λex = 312.0 nm, (B) nnonane; λex = 312.0 and (C) n-decane; λex = 312.0 nm using a 10 ns delay and 650 ns gate time. All spectra correspond to the accumulation of
100 laser pulses. The spectrograph slit was 42 μm.
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Figure B-4. 4.2 K LETRSS fluorescence spectra of 100 ng mL-1 N[2,3-a]P standard were recorded in (A) n-octane; λex =
318.0 nm, (B) n-nonane; λex = 317.0 and (C) n-decane; λex = 317.0 nm using a 0 ns delay and 25 ns gate time. All spectra
correspond to the accumulation of 100 laser pulses. The spectrograph slit was 42 μm.
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Figure B-5. 4.2 K LETRSS fluorescence spectra of 100 ng mL-1 DB[a,h]P standard were recorded in (A) n-octane; λex = 310.0
nm, (B) n-nonane; λex = 310.0 and (C) n-decane; λex = 310.0 nm using a 0 ns delay and 15 ns gate time. All spectra correspond
to the accumulation of 100 laser pulses. The spectrograph slit was 42 μm.
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APPENDIX C: FLUORESCENCE DECAYS OF HMW-PAHS IN
DIFFERENT N-ALKANE SOLVENTS AT 4.2K
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Figure C-1. Fluorescence decay of Db[a,l]P in (A) n-octane, (B) n-nonane and (C) n-decane at 4.2k
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Figure C-2. Fluorescence decay of Db[a,e]P in (A) n-octane, (B) n-nonane and (C) n-decane at 4.2k
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Figure C-3. Fluorescence decay of Db[a,i]P in (A) n-octane, (B) n-nonane and (C) n-decane at 4.2k
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Figure C-4. Fluorescence decay of N[2,3-a]P in (A) n-octane, (B) n-nonane and (C) n-decane at 4.2k
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Figure C-5. Fluorescence decay of Db[a,h]P in (A) n-octane, (B) n-nonane and (C) n-decane at 4.2k
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Figure D-1. Fluorescence intensity as a function of Db[a,l]P concentration at 4.2k in
optimum Shpol’skii solvent
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Figure D-2. Fluorescence intensity as a function of Db[a,e]P concentration at 4.2k in
optimum Shpol’skii solvent
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Figure D-3. Fluorescence intensity as a function of Db[a,i]P concentration at 4.2k in
optimum Shpol’skii solvent
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Figure D-4. Fluorescence intensity as a function of N[2,3-a]P concentration at 4.2k in
optimum Shpol’skii solvent
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Figure D-5. Fluorescence intensity as a function of Db[a,h]P concentration at 4.2k in
optimum Shpol’skii solvent
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Figure E-1. Fluorescence intensity as a function of Db[a,l]P concentration using evaporation
as pre-concentration then analysis by LETRSS
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Figure E-2. Fluorescence intensity as a function of Db[a,e]P concentration using evaporation as
pre-concentration then analysis by LETRSS
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Figure E-3. Fluorescence intensity as a function of Db[a,i]P concentration using evaporation as
pre-concentration then analysis by LETRSS

126

6

3.5x10

6

3.0x10

6

Intensity (counts)

2.5x10

6

2.0x10

6

1.5x10

6

1.0x10

y = 29891x - 3555.3

5

5.0x10

R² = 0.9975

0.0
0

20

80

60

40

100

-1

Concentarion (mg mL )

Figure E-4. Fluorescence intensity as a function of N[2,3-a]P concentration using evaporation as
pre-concentration then analysis by LETRSS
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Figure E-5. Fluorescence intensity as a function of Db[a,h]P concentration using evaporation as
pre-concentration then analysis by LETRSS
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Figure F-1. Fluorescence intensity as a function of Db[a,l]P concentration using SPNE as
pre-concentration then analysis by LETRSS
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Figure F-2. . Fluorescence intensity as a function of Db[a,e]P concentration using SPNE
as pre-concentration then analysis by LETRSS
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Figure F-3. Fluorescence intensity as a function of Db[a,i]P concentration using SPNE
as pre-concentration then analysis by LETRSS
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Figure F-4. Fluorescence intensity as a function of N[2,3-a]P concentration using
SPNE as pre-concentration then analysis by LETRSS
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Figure F-5. Fluorescence intensity as a function of Db[a,i]P concentration using SPNE
as pre-concentration then analysis by LETRSS
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Figure G. Fluorescence decay of (A) Db[a,l]P, (B) Db[a,e]P, (C) Db[a,l]P, (D) N[2,3-a]P and (E) Db[a,h]P at
4.2k from HPLC fractions and in the optimum Shpol’skii solvent
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